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 Consumers are increasingly aware of the connection between diet and heath, 
and the nutrient composition of foods is required to appropriately assess dietary intake 
and establish recommendations.  The last survey of U.S. commingled milk was in 
1984 and since then, substantial improvements in the analytical techniques of fatty 
acids (FA) have allowed for a more detailed isomer profile.  Milk contains bioactive 
FA shown to have potent anticarcinogenic and antiatherosclerotic properties, such as 
conjugated linoleic acid (CLA) and omega-3 FA. The first objective was to evaluate 
current FA composition of retail milk in the U.S. to include 1) regional and seasonal 
differences, and 2) differences among unlabeled conventional milk and milk labeled 
rbST-free or organic.  While statistical significance was reported for most FA by 
geographic region and season as well as among label type, numerical differences were 
minor, having little or no public health relevance.  These results indicate that the 
increased use of total mixed rations, lipid supplements and by-product feeding must be 
well established across all geographic regions and seasons.  In addition, when 
combined with previous analysis, results indicate that all milk is wholesome and 
nutritious regardless of production management practice.  Milk FA composition is 
highly affected by diet, thus the second objective was to naturally enhance CLA and 
omega-3 FA in milk fat through the use of dietary lipid supplements.  The first two 
studies utilized soybean oil or linseed and fish oil to enhance milk bioactive FA, with 
 the inclusion of a high dose of dietary vitamin E to mitigate diet-induced milk fat 
depression (MFD) caused by lipid supplementation. CLA content in milk fat markedly 
increased with lipid supplementation, however vitamin E had no effect.  Lastly, a 
genetically-modified soybean oil enhanced with stearidonic acid (SDA) was fed and 
resulted in impressive increases of omega-3 FA in milk fat.  Human consumption of 
omega-3 FA are well below dietary recommendations, and SDA enhanced milk may 
serve as a novel dietary source of these FA.  Methods to enhance bioactive FA in milk 
fat continue to be investigated, thus establishing the potential for improved human 
health through the consumption of dairy products. 
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CHAPTER 1 
 
INTRODUCTION 
 
 Nutrition is the foundation of human health and disease prevention.  Recent 
interests of both consumers and health professionals have been to identify foods that 
provide not only the basic building blocks of a healthy diet, but contain additional 
health benefits such as anti-oxidative, anti-carcinogenic and anti-atherosclerotic 
properties.  These foods are referred to as ‘functional foods,’ or as defined by the 
Institute of Medicine (1994) “any food or food ingredient that may provide a health 
benefit beyond the traditional nutrients it contains.”  Functional foods were originally 
investigated for plant-based foods, however the focus has now broadened to include 
food products of animal origin. 
 Consumption of milk and milk products dates back to 7,000 B.C., 
approximately 1,000 years following the first evidence of animal domestication.  
Figurines and illustrations of milking combined with carbon dating of milk fatty acid 
residues on pottery indicate consumption and storage of milk and other fermented 
dairy products (Evershed et al., 2008).  Therefore, milk has supplied essential nutrients 
for millennia.  The recent discovery of functional ‘bioactive’ foods further explains the 
important role of dairy products in the human diet.  Bioactive components in dairy 
products include whey and casein proteins, peptides, various fatty acids, calcium, 
potassium, lactose, vitamins A and D, and probiotics, to name a few (Bauman et al., 
2006c).  Of special interest are the fatty acids (FA), specifically conjugated linoleic 
acid (CLA) and omega-3 (n-3) FA. 
 Dairy products are the major source of CLA in the human diet, supplying 
~70% total intake, with ruminant meat products following at ~25% (Ritzenthaler et al., 
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2001).  CLA is unique to ruminant food sources due to the production of intermediates 
during biohydrogenation of dietary polyunsaturated fatty acids (PUFA) in the rumen, 
and subsequent endogenous synthesis of CLA in the mammary gland via ∆9-
desaturase (Corl et al., 2001).  The potent anti-carcinogenic role of CLA has been 
shown in biomedical studies with animal and cell culture models of human disease, 
and is one reason for the interest in CLA from a human health perspective (Bauman et 
al., 2006b).  n-3 FA are also bioactive FA as they serve as integral components of cell 
membranes, retinal and nervous tissue, and have been shown to improve cognition and 
neural function (Yashodhara et al., 2009).  Health professionals and scientific 
researchers have been striving to increase n-3 consumption of eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) through food fortification or natural 
enhancement, as consumption of the typical sources of these FA (i.e. fish and fish oil) 
continue to decline in the United States (Ervin et al., 2004; Gebauer et al., 2006).  The 
current concentration of CLA and n-3 in milk fat limit their potential physiological 
value, thus methods to naturally enhance milk fat content of these FA are ongoing. 
 Milk fatty acid composition in dairy cows is markedly influenced by dairy cow 
diet, and is especially sensitive to the inclusion of lipid supplements, grazing lush 
pasture and the use of total mixed rations (TMR).  As methods to improve the CLA 
and n-3 content in milk fat are identified, the need to establish a national baseline 
average of ‘typical’ milk fat composition is warranted.  The last national milk survey 
was conducted in 1984 (Barbano et al., 1990), and since then changes in the 
management and feeding of cows may have impacted FA composition.  Additionally, 
improvements in analytical techniques have allowed for the reporting of trans FA, 
CLA and other FA of human health interest.  As Jensen (1999) emphasizes, it is 
“important to know the fatty acid profiles of dairy foods in the U.S.” and concluded 
“we cannot make reliable recommendations about the health aspects of milk fat unless 
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we know the kinds and amounts of fatty acids therein”.  Moreover, the expansion of 
milk choices in the dairy case to include milk labeled by management production 
practices (eg. rbST-free and organic) has led to consumer perceptions that specialty 
labeled milk is superior in nutritional quality. To date, very few peer-reviewed 
scientific studies have investigated actual nutrient or quality differences for specialty 
labeled milk, and most have focused on individual farm sampling rather than the true 
market supply of retail milk.  Labeling claims on food products are increasingly 
popular, and solid science is needed to determine compositional differences between 
foods produced under various management systems. 
 This dissertation aims to investigate the fatty acid content of bovine milk, 
specifically the isomer distribution, range of variation and natural enhancement of 
trans 18:1, CLA and n-3 bioactive fatty acids.  The following chapters will first 
present a Review of Literature followed by results from a series of experiments.  
These investigations include two studies surveying the milk FA composition of retail 
milk in the United States, and two additional studies with the broad objective of 
obtaining a sustained, elevated milk fat content of CLA.  A final investigation 
examines the potential to enhance milk fat content of n-3 FA by using stearidonic acid 
enriched soybean oil derived from genetically modified soybeans as a means to create 
a novel food source of n-3 for the human diet.   
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CHAPTER 2 
 
LITERATURE REVIEW 
 
Fat is the most variable component in milk and can be influenced by a variety 
of factors.  Total fat production and milk fatty acid composition are affected by dietary 
supplements or ration formulations that alter rumen fermentation, and to a lesser 
extent, may also be affected by animal factors of breed, genetics and physical health 
(Palmquist et al., 1993; Jensen, 2002).  From a human health perspective, these 
variables may strongly influence the concentration of bioactive components in milk 
with properties that may be beneficial to human health and disease prevention.  The 
following sections will review rumen lipid metabolism and feeding strategies, the 
synthesis of milk fatty acids, and current research that aims to enhance the beneficial 
bioactive FA content in milk fat.  
 
LIPID METABOLISM IN THE RUMEN 
 
The rumen environment is maintained at ideal conditions for the growth of 
bacteria, protozoa and fungi that work symbiotically with the ruminant animal to break 
down feedstuffs into nutritional components that are readily available for digestion 
and absorption.  The rumen consists of a large fermentation vat of 40-50 L volume, 
with 1010 to 1011 bacteria and 105 to 106 protozoa per mL of contents (Harfoot and 
Hazelwood, 1997).  Rumen microbes are especially responsible for digesting cellulose 
and other structural carbohydrates, and utilizing non-protein nitrogen.  Constant 
supply and removal of feed and waste particles and the maintenance of an anaerobic 
environment, pH, and buffering capacity are essential to supporting the health of both 
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the rumen microbial populations and the cow herself.  Of special interest are dietary 
polyunsaturated FA, their effect on rumen fermentation, microbial digestion, and the 
production of unique FA intermediates during rumen biohydrogenation. 
 
Dietary lipid sources 
 The total fat content of a typical dairy cow diet is generally in the range of 4-
5% and consists primarily of linoleic acid (18:2; LA) supplied mainly by concentrates 
and α-linolenic acid (18:3; ALA) mainly from forages.  Plant lipids entering the 
rumen are predominantly triglycerides and glycolipids (concentrates and forages, 
respectively), with minor amounts of mono- and diglycerides, phospholipids and free 
FA (Harfoot and Hazelwood, 1997).  The FA composition of common oilseeds and 
lipid supplements can vary widely and as illustrated in Table 2.1.  
Lipid supplements are included in TMR to increase the energy content of the 
diet.  Oilseeds are commonly processed to alter physical and compositional properties 
during rumen fermentation, and examples include roasted, cracked, flaked, extruded 
and/or micronized seeds, rumen-protected lipids and liquid oils.  The form of seed 
processing will determine digestibility, availability and quantity of the lipid entering 
the rumen, and thus affect the extent of digestion by rumen microbes (Jenkins, 1993; 
Glasser et al., 2008).  However, there is a limit to the amount of lipid supplements that 
may be added to the diet, as large quantities of readily available PUFA are toxic to 
rumen microbes.  As a result, microbial populations may change and fermentation of 
carbohydrates may be altered, resulting in a reduction in microbial fermentation rates.  
Thus, only small amounts of lipid supplements are typically added to the diet to avoid 
rumen upset (Jenkins, 1993; Harfoot and Hazelwood, 1997). 
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Table 2.1.  Fatty acid composition of typical plant and marine oils and lipid 
supplements used in the formulation of ruminant diets 
 
Type of oil 16:0 18:0 18:1 18:2 18:3 EPA DHA 
Canola1 4.8 2.1 60.5 20.8 9.2 - - 
Corn2 12.3 1.9 27.7 56.1 1.0 - - 
Linseed1 6.1 3.4 18.8 16.3 54.4 - - 
Soybean1 11.4 4.1 22.3 53.5 7.0 - - 
Sunflower1 5.1 4.3 21.6 66.8 0.2 - - 
Fish3 19.8 3.4 12.6 1.3 1.2 12.7 11.2 
Ca-salt palm oil4 48.0 5.0 36.0 9.0 - - - 
Prilled fat5 39.4 36.5 10.6 1.5 - - - 
 
1Glasser et al., 2008 
2Dubois et al., 2007 
3Menhaden fish oil; Moffat and McGill, 1992 
4Megalac®; Gardner and Rudden, 2004 
5Energy Booster 100®, Milk Specialties 
 
Industrially produced rumen-protected lipid supplements are also an option to 
increase the lipid content in the TMR; such supplements may escape rumen 
fermentation allowing for intestinal absorption of intact FA that may provide FA of 
benefit for the cow’s reproduction or health, or for the improvement of milk fat 
content of bioactive FA beneficial for human health (eg. omega-3, CLA).  Examples 
of rumen-protected lipid supplements include formaldehyde-treated, provided as 
calcium salts, or encapsulated by protein matrices, pH-sensitive polymers or rumen 
inert lipids (see reviews by Wu and Papas, 1997; Jenkins and McGuire, 2006).  
Methods are continually being developed to improve the effectiveness and inertness of 
protected supplements.  In some cases these protection methods are effective at 
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mitigating the adverse effects of PUFA on rumen microbial fermentation, but 
relatively less effective or even ineffective at protecting the PUFA from rumen 
biohydrogenation.  Currently, there are no rumen-protected technologies that are fully 
protected, safe and affordable for protecting PUFA from biohydrogenation. 
 
Microbial biohydrogenation of lipids 
Plant lipids entering the rumen undergo microbial digestion in two distinct 
steps.  The first is hydrolysis of the ester linkages of FA in triglycerides, phospholipids 
and glycolipids by microbial esterases and extracellular lipases.  Hydrolysis is 
extensive and is a necessary process that must occur before the FA can be further 
metabolized.  The second step of microbial digestion is biohydrogenation of 
unsaturated double bonds.  Polyunsaturated fatty acids (PUFA) are toxic to rumen 
microbes, and it is thought that microbial hydrogenation is a protective mechanism to 
reduce PUFA toxicity.  Hydrogenation is also extensive, therefore lipids leaving the 
rumen are mostly saturated free fatty acids (see reviews by Doreau and Chilliard 
(1997) and Harfoot and Hazelwood (1997)). 
The process of biohydrogenation of LA and ALA has been described in detail 
(Harfoot and Hazelwood, 1997; Jenkins et al., 2008).  Bacteria are primarily 
responsible for all hydrogenations and isomerizations of FA, and are generally 
grouped based on their metabolic pathways; Group A bacteria hydrogenate and 
isomerize PUFA into trans FA isomers, and Group B bacteria act as a hydrogen donor 
to hydrogenate FA to form stearic acid (18:0) (Kemp and Lander, 1984). Simplified 
representations of the biohydrogenation pathways are illustrated in Figure 2.1.   
While most PUFA are completely saturated in the rumen, a small fraction of 
the intermediates in the biohydrogenation pathway pass from the rumen and are 
absorbed in the small intestine.  This provides an array of unique FA available for 
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incorporation into milk fat and adipose tissue.  Several of these intermediates are 
unique to ruminant products, such as conjugated linoleic acids (CLA) and trans fatty 
acids (TFA), whose bioactive properties are discussed in later in this chapter 
(Ritzenthaler et al., 2001; Bauman et al., 2006b).  The first isomerization step of LA in 
rumen biohydrogenation results in cis-9, trans-11 CLA, followed by hydrogenation to 
form trans-11 18:1.  Trans-11 18:1 may also be derived from ALA through a separate 
microbial biohydrogenation pathway.  A final hydrogenation of trans-11 18:1 results 
in the fully saturated FA, 18:0 (Figure 2.1; Harfoot and Hazelwood, 1997). 
There are, however, additional pathways of biohydrogenation that occur under 
certain rumen conditions such as increased lipid supplementation, sudden dietary 
changes, or decreases in rumen pH.  Therefore, biohydrogenation intermediates can 
shift depending on feedstuff and diet formulation, as microbial populations also shift 
to adjust to the new environment and create alternative pathways of biohydrogenation 
(Harfoot et al., 1973; Chilliard et al., 2007; Jenkins et al., 2008; Figure 2.2).  Few 
PUFA are subject to the alternative pathways, therefore only small amounts of other 
CLA and trans FA isomers are produced.  One such CLA isomer is trans-10, cis-12 
18:2, which has been shown to induce milk fat depression (MFD) even at low 
concentrations, as discussed in the next section (see reviews by Shingfield and 
Griinari, 2007; Bauman et al., 2008).  Therefore, challenges to avoid or minimize 
MFD is a struggle for dairy farmers and nutritionists when trying to increase the lipid 
content of the diet, and for researchers developing feeding strategies to naturally 
enhance specific bioactive FA in milk fat. 
 
 
 
 
 9 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.   Pathways of typical rumen biohydrogenation of linolenic and linoleic 
acids.  Modified from Bauman et al., 2003. 
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Figure 2.2.  Pathways of altered rumen biohydrogenation of linoleic acid.   
Modified from Bauman et al., 2003. 
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MILK FAT SYNTHESIS 
 
 The mammary gland consists of a lobulo-alveolar system of secretory 
epithelial cells surrounded by contractile myoepithelial cells and blood vessels to form 
alveoli.  Alveoli are grouped into lobules and lobes, and are connected to a ductal 
system for the removal and transport of milk to the gland cistern and teat for 
expression (Reece, 1997).  The secretory cell serves as the basic functional unit, 
responsible for synthesizing and secreting most milk components through two cellular 
processes: exocytosis of non-fat milk components from golgi-derived vesicles and 
budding or pinching off of intracellular milk lipid droplets (Mather and Keenan, 
1998).  The synthesis and secretion of fatty acids into milk fat globules is discussed. 
 
Milk fat globules 
Milk fat globules contain 97% triglyceride, <1% phospholipid and the 
remaining 2% as cholesterol esters, di- and monoglycerides and free fatty acids 
(Bitman and Wood, 1990).  The core of the milk fat globule consists of hydrophobic 
triglycerides surrounded by a membrane.  This milk fat globular membrane, composed 
of phospholipids, proteins, and cholesterol, forms during the budding-off process of 
milk fat secretion.  Lipid droplets originate from the rough endoplasmic reticulum 
where triglycerides are synthesized by membrane-bound enzymes.  The resulting 
microlipid droplets grow in size as they merge together to form larger droplets during 
their intracellular transit to the apical membrane.  The exact method of transport is 
unclear; however, there is some evidence that microtubules and microfilaments of the 
cytoskeleton are involved (Mather and Keenan, 1998). 
Lipid droplets are secreted at the apical membrane through a process of 
enveloping and pinching off of the lipid droplet, which may also include fragments of 
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cytoplasm and other cellular contents (Huston and Patton, 1990).  The resulting milk 
fat is surrounded by the milk fat globular membrane, preventing coalescence with 
other fat globules and allowing for proper removal from the mammary gland.  
Droplets in unhomogenized milk range in size from < 1 to 12 µm, with large droplets 
(> 4 µm) providing 90% of the total lipid by volume, while small droplets (< 1 µm) 
comprise 80% of total droplets by number (Jensen et al., 1991).  There are small 
differences in the FA composition of fat globules of different sizes (Michalski et al., 
2006); however, the main differences are the proportion of triglyceride and 
phospholipid, due to relationship between surface area and core volume.   
 
Fatty acid composition 
 Milk fat contains a wide range of SFA, MUFA and PUFA, and is one of the 
most diverse sources of FA, containing over 400 different isomers (Jensen, 2002).  
The unique process of rumen biohydrogenation together with the desaturase enzymes 
in the mammary gland allow for the diverse FA profile.  Milk FA originate from two 
sources in near-equal molar proportion, preformed FA and FA that are endogenously 
synthesized de novo (Bauman and Davis, 1974).  Preformed FA are long chain FA 
(>16C) that are taken up from blood circulation, originating from absorption from the 
digestive tract or mobilized from body fat stores.  The proportion of preformed FA 
from body stores will vary depending on the metabolic state of the cow.  For example, 
the contribution is greater in early lactation when cows are in negative energy balance 
and circulating non-esterified FA are elevated.  The other source of FA in milk fat is 
the de novo FA, which are short and medium chain FA (<16C) made new within the 
mammary gland.  FA up to 16 carbons in length are synthesized from acetate and β-
hydroxybutyrate via acetyl-CoA carboxylase and fatty acid synthase (Barber et al., 
1997; Bauman and Griinari, 2001).  Therefore, 16C FA originate both from preformed 
 13 
and de novo FA sources, and are commonly excluded from both categories when 
describing changes in milk FA source.  The contributions of preformed and de novo 
FA in milk fat may be altered by metabolic or physiological state of the cow, 
especially during diet-induced milk fat depression. 
 
Milk fat depression 
One of the most highly investigated influences on milk FA composition is the 
occurrence of low-fat milk syndrome, or MFD.  MFD has been recognized for over a 
century and is characterized by a decrease in milk fat synthesis without decreases in 
milk yield or other milk components (Table 2.2) (Bauman and Griinari, 2001).  
Changes in the milk FA composition involve an overall reduction of total FA content, 
with a greater decrease in the molar reduction of de novo FA than that of preformed 
FA (Harvatine et al., 2009). 
Several causational theories of diet-induced MFD have been proposed and can 
be broadly grouped into two general categories: 1) diets that cause a reduction in the 
availability of precursors for milk fat synthesis, and 2) direct inhibition of one or more 
enzymatic steps in the milk fat synthesis pathway by rumen biohydrogenation 
intermediates (see reviews by Bauman and Griinari, 2001; Harvatine et al., 2009).  Of 
these theories, only the ‘biohydrogenation theory’ has been verified and current 
investigations seek to establish direct relationships between alterations in rumen 
biohydrogenation and milk fat depression. 
 Altered rumen biohydrogenation, as discussed previously, results in the 
production of trans-10, cis-12 CLA and trans-10 18:1.  The biohydrogenation theory 
is based on evidence that alternative intermediates (i.e. CLA and trans 18:1 isomers) 
produced during rumen biohydrogenation have a direct negative effect on the 
synthesis and secretion of milk fat.  Trans-10, cis-12 CLA has been extensively 
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investigated (see review by Bauman et al. (2008)).  This CLA isomer reduces milk fat 
synthesis on a dose-dependent basis with a maximum reduction in milk fat yield of 
50% (Baumgard et al., 2001; de Veth et al., 2004).  Two additional CLA isomers have 
also been identified that inhibit milk fat synthesis, trans-9, cis-11 18:2 and cis-10, 
trans-12 18:2; however, their potency appears to be less than that of trans-10, cis-12 
18:2 (Saebo et al., 2005; Perfield et al., 2007).  
 
 
Table 2.2.  Summary of milk component and fatty acid (FA) compositional changes 
due to diet-induced milk fat depression (MFD)1 
 
Variable Observed change during MFD 
Milk yield No change 
Milk component yield  
      Fat Decrease (up to 50%) 
      Protein No change 
      Lactose No change 
Milk fatty acid composition  
      De novo FA2 Pronounced decrease 
      Preformed FA3 Modest decrease 
      Trans-10, cis-12 CLA Generally increased 
      Trans-10 18:1 Increased 
 
1Adapted from Bauman and Griinari, 2001 
2Fatty acids less than 16 carbons in length, endogenously synthesized in the mammary 
gland 
3Fatty acids greater than 16 carbons in length, originating from the uptake of 
circulating blood lipids 
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Changes in milk FA composition and total milk fat yield have industrial and 
economic effects for both dairy manufacturers and dairy farmers.  Milk FA 
composition accounts for many of the physical properties, manufacturing 
characteristics and organoleptic qualities of milk; when mean FA chain length and 
degree of saturation are modified, resistance to oxidation, melting properties and 
product flavors may also change (Palmquist et al., 1993; Kaylegian, 1995; Collomb et 
al., 2006).  However, the more devastating consequence of MFD is the economic loss 
to the dairy farmer, as milk receipts are based on total fat and protein components.  
Therefore, to prevent potential economic costs to both the producer and dairy 
manufacturer, dairy nutritionists formulate rations to minimize the risk of diet-induced 
MFD. 
 
BIOACTIVE FATTY ACIDS IN MILK 
 
Milk fat has among the most diverse fatty acid composition of all human food 
products. The unique involvement of microbial biohydrogenation, enzyme 
desaturation and origin of FA in milk fat generates a product with over 400 different 
FA isomers.  Of these, several have been identified as bioactive FA due to their 
potential to benefit the maintenance of human health and prevention of chronic and 
acute diseases.  However, other FA have been implicated as detrimental with potential 
negative impacts on cardiovascular health and coronary heart disease.  These FA are 
discussed in the following sections.  
 
Conjugated linoleic acid 
Conjugated linoleic acids represent a mixture of octadecadienoate (18:2) 
isomers with two double bonds in a conjugated configuration. The location and 
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Figure 2.3.  Chemical structures of linoleic acid, cis-9, trans-11 18:2 CLA and trans-
11 18:1.  Arrows indicate double bonds in cis and trans configuration.  
Modified from Bauman et al., 2006b 
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stereospecificity of the double bonds allows each isomer to have different 
physiological and bioactive properties, as cis and trans double bonds determine the 
physical and geometric structure of each CLA isomer.  Figure 2.3 demonstrates these 
structural differences through comparison of three FA involved in the rumen 
biohydrogenation pathways previously outlined in Figure 2.1.   
Cis-9, trans-11 18:2 is the predominant CLA isomer in milk and meat products 
(70-95% of total CLA), and has been given the common name rumenic acid (RA) 
because of its unique presence in ruminant foods (Lock and Bauman, 2004).  The 
intake of CLA in the human diet is almost exclusively provided by ruminant-derived 
sources (Ritzenthaler et al., 2001; Figure 2.4).  During rumen biohydrogenation of LA, 
the first isomerization step produces RA.  Most RA is further hydrogenated to trans-
11 18:1 (vaccenic acid; VA) and finally to stearic acid (18:0), but some RA and VA 
escape the rumen prior to complete saturation and are absorbed from the small 
intestine (Figure 2.1).  In the mammary gland, VA is converted to RA via the enzyme 
∆9-desaturase, and this conversion accounts for >70% of the total RA secreted in milk 
fat, with the remainder originating from the RA that escaped complete rumen 
biohydrogenation (Corl et al., 2001).  ∆9-desaturase inserts a cis double bond in the 9th 
position from the carboxyl end of the fatty acid and its activity varies depending on 
substrate/product regulation, genetic expression, and direct inhibition by certain FA 
(Ntambi and Miyazaki, 2004).  The predominant reaction of mammary ∆9-desaturase 
is the conversion of stearic acid to oleic acid and this reaction is important for 
regulating milk fat fluidity, as the melting point lowers with increased unsaturated FA 
content (Palmquist et al., 1993).  Thus, RA concentration in milk fat may be altered 
through ∆9-desaturase activity or through incomplete biohydrogenation of CLA in the 
rumen. 
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Figure 2.4.   Dietary sources of cis-9, trans-11 conjugated linoleic acid.  Modified 
from Ritzenthaler et al., 2001. 
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Booth and colleagues (1935) were first to identify the presence of conjugated 
double bonds in milk fat during an examination of differences in IR analysis of 
summer and winter milk fats.  Then in 1977, Parodi identified that RA was the specific 
milk FA isomer containing the conjugated double bond.  In the following years, Pariza 
and colleagues demonstrated that a compound in beef fat inhibited mutagenesis and 
coined the term conjugated linoleic acid (Pariza et al., 2004).  Interest in CLA grew 
exponentially thereafter and research to investigate the effects of CLA on 
carcinogenesis expanded.  During this time, researchers used various cell culture and 
animal models to investigate the biology of CLA and discovered additional biological 
effects that included prevention of chronic and acute diseases such as atherosclerosis, 
obesity, and immunological dysfunction (see reviews by Belury (2002), Parodi (2004), 
Bauman et al. (2006b), and Collomb et al. (2006)).   
Initial studies of CLA used mixed isomer preparations, but as research 
continued, pure RA became available and the presence and importance of other CLA 
isomers gained attention, especially trans-10, cis-12 18:2.  Trans-10, cis-12 18:2 has 
been shown to have potent effects on MFD, adiposity, prevention of cancer and 
atherosclerosis, and the development of insulin resistance.  Literature relevant to the 
bioactive properties of trans-10, cis-12 18:2 and other CLA isomers can be found in 
reviews by Belury (2002) and Bauman et al. (2008); meanwhile, this dissertation will 
continue to focus solely on the health aspects of RA.   
RA has been consistently demonstrated to be a potent anticarcinogen in 
biomedical models of human cancer.  Initial studies utilized industrially-synthesized 
mixtures of CLA isomers in mice models with chemically-induced tumors.  
Researchers found that tumor incidence decreased by 50% compared to control and 
LA dosed mice (Ha et al., 1987).  Ip and colleagues (1999) further investigated the 
effects of CLA when they compared synthetic and naturally occurring RA sources; the 
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natural RA source was a butter made specifically from cows fed diets designed to 
enhance RA content of milk fat (Bauman et al., 2000).  Their results indicated a 
similar decrease in chemically-induced mammary tumors in rat models as in previous 
studies (~50%), however, the use of naturally-enriched butter allowed additional 
tumor protection and greater accumulation of RA in mammary tissue (Ip et al., 1999).  
The investigators hypothesized that the higher VA content in RA-enriched butter 
contributed to the RA pool through endogenous synthesis via ∆9-desaturase.  Griinari 
and colleagues (2000) confirmed the role of endogenously derived RA in a study 
demonstrating the reduction of RA concentration in milk fat from dairy cows 
administered sterculic oil, an inhibitor of ∆9-desaturase activity.  Other products of ∆9-
desaturase were also reduced (myristoleic acid, 14:1; palmitoleic acid, 16:1; oleic acid, 
18:1), further establishing the importance of this enzyme in regulating milk fatty acid 
composition.  In similar studies using rat models, the anticarcinogenic effect of VA 
was shown to be directly dependent on its conversion to RA (Corl et al., 2003; Lock et 
al., 2004).   
An important aspect of the effectiveness of RA on preventing mammary cancer 
is the timing of RA consumption relative to the growth and development of mammary 
tissue.  RA consumed in the pre-pubertal period establishes a reservoir of RA in the 
adipose tissue in the mammary gland that offers protection later in life to chemically-
induced cancer.  Post-pubertal protection requires continuous consumption of RA 
throughout the period when the chemical carcinogen is given in order for RA to offer a 
protective effect against tumor development (Ip et al., 1995).  Additionally, the ability 
to demonstrate RA activity in human subjects proves to be difficult due to the long 
latency periods of cancer development, poor assessment of dietary RA intake, and lack 
of effective biomarkers of disease (Bauman et al., 2006b).  Several epidemiological 
studies with human subjects have reported mixed results of the effect of RA on breast 
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cancer, further verifying difficulty of studying RA in human subjects (Lock et al., 
2005).  Therefore, extrapolation of data from animal models have been used to 
estimate a human physiologically effective dose of RA.  However, it is important to 
recognize that the animal studies have typically administered a massive dose of 
carcinogen so that 100% of the animals develop multiple tumors in a short period of 
time. Nevertheless, based on metabolic body weight, the calculated daily consumption 
of RA to be physiologically effective is estimated to be ~700-800 mg (Bauman et al., 
2006b).  The current concentration of RA in milk fat is not great enough to supply this 
amount within the bounds of the USDA recommended daily consumption of dairy 
products.  Thus research is ongoing to establish viable methods to sustain a naturally-
enhanced RA content in milk fat; these methods are discussed later in this chapter. 
In regards to the effect of CLA on human health, the National Academy of 
Science stated that “conjugated linoleic acid is the only fatty acid shown 
unequivocally to inhibit carcinogenesis in animal models” (NRC, 1996).  Over the last 
15 years, extensive research has continued to uphold and further verify this statement. 
 CLA has been less extensively studied for its effects on cardiovascular disease 
(CVD).  Nearly all studies have use synthetic mixtures of CLA isomers in animal 
models of atherosclerosis and results have been inconsistent, ranging from improved 
plasma lipoprotein profile (Lee et al., 1994; Nicolosi et al, 1997) to reports of CLA 
promoting lesion development (Munday et al., 1999).  However, when pure isomers of 
RA became available, studies demonstrated that RA improved regression of 
atherosclerotic lesions in rabbits (Kritchveski et al., 2004) and improved hepatic 
cholesterol metabolism in humans (Noone et al., 2002; Tricon et al., 2004).  
Additionally, the comparison between RA and trans-10, cis-12 CLA on plasma 
cholesterol could be examined; results showed that these isomers have divergent 
biological effects in that RA improved plasma cholesterol by lowering LDL, 
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HDL:LDL, and total:HDL cholesterol ratios, whereas trans-10, cis-12 CLA reduced 
HDL cholesterol and increased LDL:HDL and total:HDL cholesterol ratios (Tricon et 
al., 2004).  Emerging evidence from similar studies examining the differences between 
CLA isomers on several chronic diseases indicates that RA and trans-10, cis-12 CLA 
are not equal in biological effect and should be considered separately (Bauman et al., 
2006b).  Lastly, application of naturally derived RA in butter demonstrated a reduction 
of total, very-LDL and LDL plasma cholesterol concentrations when fed to Golden 
Syrian hamsters given a high fat, high cholesterol diet (Lock et al., 2005).  
Investigations to further identify the bioactive properties of RA on atherosclerosis are 
required, however, the limited studies suggest a promising use of RA in the prevention 
of chronic diseases (see review by Bauman et al., 2006b). 
 
Saturated and trans fatty acids 
Not all FA in milk are considered beneficial, as milk contains both saturated 
and trans FA.  A link between an increased risk of CVD and diets high in SFA has 
been emphasized for decades, and more recently intake of TFA have been shown to 
represent a risk for CVD as well (National Research Council, 1989; USDHHS/USDA, 
2005).  However, the concept that consumption of dairy products represents an 
increased risk of CVD is not supported by recent scientific evidence (Elwood et al., 
2004; German et al., 2009; Parodi, 2009).  Research related to the risk of CVD and 
intake of SFA and TFA are discussed below. 
Milk and meat products contain ~60% SFA, but not all SFA are identical in 
physiological effects.  Short chain SFA (4:0, 6:0, 8:0, and 10:0) are readily 
metabolized so they are considered to represent no CVD risk, and 18:0 intake has also 
been shown to have no relation to the risk of CVD (Jensen, 2009).  The remaining 
SFA are lauric (12:0), myristic (14:0) and palmitic (16:0) acids.  These FA are 
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considered an atherogenic risk because they increase plasma concentrations of low-
density lipoprotein (LDL) cholesterol (Kris-Etherton and Yu, 1997).  However, they 
also increase plasma concentration of high-density lipoprotein (HDL) cholesterol and 
this is indicative of a reduced risk for CVD.   With the updated equation for the risk 
ratio of CVD to include changes in HDL cholesterol, a meta-analysis of the effects of 
SFA based on data from 60 clinical studies demonstrated that the plasma ratio of total 
cholesterol:HDL-cholesterol provided little evidence that dietary intake of 12:0, 14:0 
and 16:0 represented an atherogenic risk when compared to an isocaloric substitution 
of carbohydrate (Mensink et al., 2003). Furthermore, recent epidemiological studies 
and large-scale clinical investigations have challenged the perception that saturated fat 
intake is a risk factor for CVD (Hooper et al., 2001; Taubes, 2001; Howard et al., 
2006; Mente et al., 2009). 
When the harmful effects of SFA were first reported in the 1970s, the food 
industry developed partially hydrogenated vegetable oil (PHVO) as a replacement for 
butter and lard.  This alternative spreadable fat was made from liquid vegetable oil 
hydrogenated to mimic the physical properties of butter by converting PUFA to 
monounsaturated TFA.  In the last two decades, TFA have increasingly gained 
attention for their reported negative effects on CVD.  The initial studies investigated 
industrial sources of TFA in PHVO and showed that the consumption of PHVO 
increased the ratio of LDL-cholesterol to HDL-cholesterol, and this effect was 
strongly correlated with the high TFA content (Willett and Stampfer, 1993; Mensink 
et al., 2003; Mozaffarian et al., 2006).  However, TFA are also naturally present in 
ruminant-sourced foods, in particular milk and meat fats.  Initially it was assumed this 
natural source of TFA would also be associated with an increased risk of CVD; 
however, recent work has indicated that TFA intake from ruminant-derived foods does 
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not represent a risk for CVD (Lock et al., 2005; Jakobsen et al., 2008; Stender et al., 
2008).   
Differences between the source of TFA and the risk of CVD may be explained 
by the isomer distribution and total content of TFA in ruminant versus industrial fat 
sources.  Human dietary intake of TFA is ~80% from industrial sources due to the use 
of PHVO in baking, margarine and manufacturing of other foods 
(http://vm.cfsan.fda.gov/~dms/qatrans2.html).  The remaining 20% comes from
 
 
 
 
 
Figure 2.5.  Isomer distribution of trans fatty acids in ruminant fat (butter) and 
partially hydrogenated vegetable oil (margarine).  Adapted from Lock et 
al., 2005. 
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natural sources represented by dietary intake of dairy products and meat from 
ruminants.  PHVO consists of ~60% TFA of total FA and the isomer distribution is a 
Gaussian distribution centering on trans-9 and trans-10 18:1 (Lock et al., 2005; 
Destaillats et al., 2008).  In contrast, ruminant fats contain ~3% TFA and consist 
mainly of trans-11 18:1 (VA, discussed previously; Figure 2.5).  Of the TFA, only VA 
has been extensively investigated for potential health benefits related to its association 
with CLA.  Additionally, few studies have directly examined the effect of individual 
TFA isomers on CVD and found no negative effects of trans-9 18:1 or VA on plasma 
cholesterol ratios (Meijer et al., 2001; Tyburczy et al., 2009).  Thus, the association of 
dietary intake of industrial TFA on risk of CVD is purely based off correlations and 
the factors responsible for increased ratio of cholesterol may be due to unusual FA in 
PHVO, rather than the trans 18:1 FA.  Nevertheless, TFA have been highly publicized 
as fats to avoid, and this recommendation has often been extended to the TFA in dairy 
and meat products. 
 
Omega-3 fatty acids 
Omega-3 (n-3) FA are increasingly recognized for their potential benefits to 
human health and have become highly visible in the marketplace through product 
labeling of foods that have enhanced n-3 FA content, such as fish, eggs, bread, and 
infant formula.  n-3 FA have been extensively investigated in animal and human 
controlled clinical studies for their effects on cardiac health, atherosclerosis, 
inflammation, diabetes, retinal function, neurological disorders and fetal development 
(Simopoulos, 1999; Gebauer et al., 2006; Yashodhara et al., 2009).  Biosynthesis and 
interconversion of n-3 FA is illustrated in Figure 2.6; α-linolenic acid (18:3 n-3; ALA) 
is an essential n-3 FA in the human diet and can be converted to all of the downstream 
n-3 FA by enzymes expressed in human tissues (Whelan and Rust, 2006).  While ALA 
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is required for normal growth and development, most of the health benefits related to 
n-3 apply only to the very long chain (VLC) n-3 PUFA, eicosapentaenoic acid (20:5 n-
3; EPA) and docosahexaenoic acid (22:6 n-3; DHA).  Dietary sources of EPA and 
DHA are predominantly fish, fish oil, and marine algae, whereas ALA is commonly 
found in terrestrial plant oils such as linseed, soybean and walnuts (Gebauer et al., 
2006; Lavie et al., 2009).  Unfortunately, the ability to convert ALA to EPA and DHA 
is severely limited in humans (Arterburn et al., 2006; Brenna et al., 2009). 
n-3 intake is of concern to nutritionists and has led to dietary recommendations 
to improve consumption.  LA and ALA have been recognized as essential FA for 
decades and have been issued adequate intakes (AI) by the Institute of Medicine of the 
National Academies (IOM, 2005).  However, as research grew to understand the 
importance of nutrients in preventing chronic diseases as well as avoid symptomatic 
deficiencies, recommendations expanded to include benefits of other n-3 FA.  As such, 
the American Dietetic Association issued a recommended intake of 500 mg/d of EPA 
and DHA in order to achieve additional health benefits of VLC n-3 PUFA 
consumption (Gebauer et al., 2006; Kris-Etherton et al., 2009).   
 n-3 supplementation has been extensively investigated in controlled human 
dietary clinical studies to determine conversion rates of ALA to EPA and DHA as 
measured in plasma lipids, platelets, and red blood cells.  Nearly all studies report that 
high dietary supplementation of ALA results in small increases in EPA concentration 
in blood fractions, with kinetic studies suggesting <1 to 7% conversion of ALA to 
EPA.  However, conversion to DHA is even more limited and does not significantly 
improve DHA concentrations (see review Brenna et al., 2009).  Similarly, when EPA 
supplements were offered, EPA content increased without a corresponding DHA 
increase.  The poor conversion of n-3 FA can be partly explained by the rate-limiting 
enzyme, ∆6-desaturase (Whelan and Rust, 2006).  As illustrated in Figure 2.6, the first 
27 
 
 
 
 
 
Figure 2.6.   Biosynthesis of omega-3 fatty acids 
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enzymatic step of n-3 biosynthesis begins with ALA desaturation to stearidonic acid 
(18:4 n-3; SDA); recent studies have shown that dietary SDA bypasses ∆6-desaturase 
limitations by effectively increasing EPA content in tissue and plasma lipids, and 
modest levels of SDA supplementation can achieve results that are comparable to EPA 
supplementation (James et al., 2003; Ursin, 2003; Harris et al., 2008).  Furthermore, 
∆6-desaturase is responsible in part for the conversion of EPA to DHA and studies 
have indicated that EPA supplementation is not a viable method to effectively increase 
tissue DHA content (Brenna et al., 2009; Whelan, 2009).  Thus, ∆6-desaturase is the 
rate-limiting enzyme in n-3 biosynthesis, and recommendations to increase EPA and 
DHA consumption regardless of ALA intake are warranted. 
 The recommendation to increase VLC n-3 consumption is further supported 
due to competition and antagonism for shared enzymes between n-3 and omega-6 (n-
6) FA during endogenous biosynthesis.  With increased consumption of n-6 FA, the 
potential for ALA to be converted to EPA and DHA is further reduced while the 
conversion of LA to longer chain n-6 improves.   Over the last 30 years, consumption 
of corn, sunflower and other plant oils high in linoleic acid (18:2 n-6; LA) has 
increased, with concurrent decreases in the consumption of fish and fish oils due to 
taste preferences, reports of harmful toxins (eg. mercury) and other moral or 
environmental concerns (Gebauer et al., 2006).  Thus, the current dietary intake ratio 
of n-6:n-3 FA is estimated to be 20:1, whereas the suggested ratio to avoid competitive 
inhibition is 2:1 (Simopoulos, 1999; Kris-Etherton et al., 2009).  Although n-6:n-3 
ratio is influential for biosynthesis, the emphasis to improve these ratios should focus 
on total consumption of these FA by reducing LA intake, rather than solely increasing 
EPA and DHA intake (Kris-Etherton et al., 2000). 
Providing alternative, non-traditional dietary sources of EPA, DHA, and other 
VLC n-3 PUFA is a current research focus (Whelan and Rust, 2006).  One such 
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method is the genetic modification of soybeans to produce soybean oil with enhanced 
SDA content.  Feeding the oil supplement would improve n-3 concentration in food 
products, such as milk fat from dairy cows, eggs from chickens, or meat from farm 
animals or farmed fish.  Milk fat n-3 FA consists primarily as ALA in very low 
concentrations (Jensen, 2002), however, feeding rumen-protected SDA-enhanced 
soybean oil to dairy cows may be one application to provide an additional n-3 source 
in the human diet, with the added benefit of using a nutrient dense vehicle that also 
contains high quality protein, energy and essential nutrients. 
Differentiating the biological properties of individual FA is a growing area of 
research that has proven to be of value in determining the effects of FA on human 
health and well-being.  FA should no longer be generally grouped by family, degree of 
saturation or double bond configuration, but recognized for their unique bioactive 
properties.  Additionally, education of health professionals and consumers is necessary 
to convey these differences in order to benefit human health and prevent chronic and 
acute diseases. 
 
METHODS TO NATURALLY ENHANCE CONJUGATED LINOLEIC ACID 
AND OMEGA-3 FATTY ACIDS IN MILK FAT 
 
 The potential to improve human health through the use of dairy products with 
naturally enhanced bioactive FA is an exciting opportunity for both researchers and 
health professionals.  The composition of milk fat is influenced by a variety of factors 
that can be grouped into two general categories: animal and dietary factors (Jensen, 
2002).  Milk FA composition is tightly linked to feed components and rumen outflow 
of FA, however genetic polymorphisms and the regulation of enzymes involved in FA 
synthesis or desaturation can also be influential.  Investigations with the objective to 
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enhance milk bioactive FA have been reviewed (Jensen, 2002; Bauman and Lock, 
2006; Collomb et al., 2006; Chilliard et al., 2007); however, increasing bioactive FA 
in milk to a level that is physiologically effective without inducing MFD remains a 
challenge.  Thus, methods to increase CLA and n-3 FA in milk fat continue to be 
highly active areas of research and are discussed below. 
 
Individual animal variation 
 The effect of breed, parity, and stage of lactation have been investigated as 
potential factors in determining milk FA composition.  The most extensive study was 
reported by Kelsey and colleagues (2003) in which 113 Holstein and 106 Brown Swiss 
cows were examined for differences in milk fat CLA content and ∆9-desaturase index 
as related to variation among individuals.  The authors reported that CLA varied ~3 
fold among individuals, (0.24 to 0.72% total milk FA); however, less than 2% of the 
total variation could be attributed to the effects of breed, parity, and days in milk 
combined.  Additional studies by Lawless et al. (1999), White et al. (2001), and 
Peterson et al. (2002) reported a similar range of CLA content in milk fat; however, 
these studies varied in dietary treatments or were limited in animal number.  
Interestingly, these studies also demonstrated that the individual variation among cows 
maintained a hierarchy over time; cows that had greater CLA content in milk fat 
continued to be the top producers throughout dietary challenges designed to alter milk 
FA composition.  In more recent studies investigating genetic parameters on milk fat, 
Stoop et al. (2008) and Mele et al. (2009) reported that CLA content ranged from 0.25 
to 0.61, and 0.10 to 1.34% of total milk FA, respectively; both authors concluded that 
milk FA composition could be improved by selective breeding due to genetic 
heritability. 
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The effect of animal variables on the milk fat content of n-3 FA have been 
investigated to a lesser extent.  Kelsey et al. (2003) reported ALA content to have 
about a 2-fold range among individual cows (0.22 to 0.54% of total milk FA), of 
which milk fat ALA content was unaffected by breed, parity, or stage of lactation.  
This 2-fold range was confirmed by White et al. (2001), where dietary treatment was 
the only significant variable on ALA content in milk fat.  Furthermore, Stoop et al. 
(2008) analyzed milk FA composition from 1,918 cows in the Netherlands and 
reported ALA to have a range of 0.27 to 0.61% of total milk FA.  Although a 2-fold 
range is impressive, animal and physiological variables are minor compared to the 
effect of dietary variables (Bauman and Lock, 2006), and thus the remainder of this 
section will focus on forage source and lipid supplements. 
 
Effect of forage source 
Milk fat content of CLA and n-3 FA can vary according to the source of forage 
in the diet (Table 2.3).  Forages typically include hay and pasture-based diets, or corn 
and hay-crop silage-based diets.  During the summer months when fresh pasture is 
available, investigations have consistently shown that VA, CLA, and ALA increase 2-
3 fold in milk fat as compared to corn silage-based diets (Precht and Molkentin, 1996; 
Jahreis et al., 1997; Kelly et al., 1998b; White et al., 2001; Kay et al., 2005; Heck et 
al., 2009).  Additionally, Kraft and colleagues (2003) observed increases in SDA, EPA 
and DPA with pasture grazing in the Swiss Alps as compared to indoor diets based on 
conserved forages and high concentrates.  However, this effect is most pronounced 
when cows are grazed on lush pasture, and effects are mitigated as the pasture matures 
or the diet includes additional feedstuffs (Kelly el al., 1998b; Auldist et al., 2002; 
Heck et al., 2009).   
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Differences in milk FA composition as affected by forage and forage quality 
can in part be explained by the type and amount of PUFA in the feedstuff.  Hay and 
hay crop silages contain predominantly ALA as a percent of total FA as compared to 
corn silage, which is comprised mostly of LA (Dhiman et al., 2005; Shingfield et al., 
2005).  Additionally, forage quality can change over the growing season; pasture 
forages can vary such that in the early spring, pasture grass is immature and contains a 
greater quantity of PUFA and lower fiber per DM than mature pasture forages.  The 
effect of pasture maturity has been shown to negatively impact milk fat CLA content, 
ranging from 0.48 to 1.14% total FA in milk from cows fed grass silages cut at mature 
(flowering) and immature (heading) stages (Chouinard et al., 1998).  Similarly, 
Auldist and colleagues (2002) clearly demonstrated that when cows were grazed on 
pasture, milk fat CLA content was greatest in the early spring and lowest in the late 
summer.  Furthermore, in studies investigating the changes in milk FA composition 
over time, the increases of milk fat CLA and ALA mirror the intake of fresh pasture in 
the spring and decrease in the fall when cows are switched to winter diets containing 
conserved forages (Lock and Garnsworthy, 2003; Heck et al., 2009).   
 
Effect of dietary supplements 
 Although forage source affects milk fat CLA content, oil and oilseed 
supplements are more effective because they directly provide the necessary PUFA 
precursors of CLA and VA in high quantities (Palmquist et al., 2005).  Oilseeds may 
be supplemented through a variety of physical forms (Table 2.1) and this can impact 
the CLA content of milk fat (Table 2.3).  The degree of processing or processing 
technique will disrupt the protective oilseed coat and increase lipid access for the 
rumen microbes, thus initiating biohydrogenation (Jenkins, 1993; Ashes et al., 1997; 
Glasser et al., 2008).  In a study by Chouinard et al. (2001), the inclusion of extruded, 
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micronized, or roasted soybeans in the diet increased CLA content in milk fat 2-3 
times greater than the addition of raw, ground soybeans.  Similarly, Dhiman et al. 
(2000) examined diets supplemented with raw cracked soybeans, roasted cracked 
soybeans, soybean oil or linseed oil, and reported that PUFA in liquid oil form was 
twice as effective at increasing the CLA content of milk fat as compared to using 
roasted cracked soybeans, and four times as effective than using raw cracked 
soybeans.  However, a partially intact oilseed coat releases lipid gradually in the 
rumen, thus mitigating diet-induced MFD that is more commonly seen when liquid oil 
is supplemented (Grummer, 1991). 
In addition to processing technique, FA composition of the supplemented oil 
may impact rumen biohydrogenation and milk FA profile.  As previously described in 
Table 2.1, oil supplements can vary in degree of saturation, ranging from common 
commercial energy supplements rich in SFA (Megalac® and Energy Booster®) to 
highly unsaturated plant oils, most of which are rich in 18:2 (corn, soybean and 
sunflower), or 18:3 (linseed and flaxseed).  Unlike PUFA, saturated fat is not toxic to 
rumen microbes and does not negatively affect biohydrogenation or milk fat synthesis; 
however, because cows lack the enzymes to synthesize CLA, LA and ALA from 
saturated fats, feeding SFA does not result in increases of these beneficial FA in milk 
fat (Chilliard et al., 2000).  Thus, to enhance bioactive FA, lipid supplements rich in 
PUFA are required. 
Several studies have investigated the effects of supplementing various plant 
oils rich in LA or ALA on CLA content in milk fat.  Figure 2.1 illustrates the 
biohydrogenation pathways of these two PUFA; LA is a direct precursor of CLA 
during rumen biohydrogenation and has the potential to increase its content in milk fat 
more effectively than ALA would at similar doses.  However, the majority of CLA 
secreted in milk fat originates from endogenous synthesis of CLA from VA, not from 
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rumen biohydrogenation, thus both LA and ALA are equally effective precursors of 
CLA in milk fat (Lock and Bauman, 2004).  Nevertheless, results from individual 
studies are somewhat inconsistent and have reported plant oils rich in LA to be more 
effective at enhancing milk fat CLA content (Dhiman et al., 2000; AbuGhazaleh et al., 
2003; Bu et al., 2007), whereas others have reported no difference (Loor et al., 2005b; 
Rego et al., 2009).  These discrepancies may be due to interactions with feedstuffs in 
the basal diet, quantity of lipid supplemented, length of study, or overall experimental 
design.  However, when results are grouped and analyzed in reviews and meta-
analyses, the effects of LA and ALA on milk fat CLA content are comparable 
(Chilliard et al., 2007; Glasser et al., 2008).   
There are some benefits of supplementing plant oils rich in ALA as compared 
to LA.  Diet-induced MFD was observed in several studies supplementing oils rich in 
LA, whereas this same result was not observed when ALA was supplemented 
(AbuGhazaleh et al., 2003; Rego et al., 2009).  This difference may be related to 
biohydrogenation pathways and intermediates produced during altered rumen 
fermentation; unlike ALA, LA can be isomerized into alternative CLA isomers that 
are known to inhibit milk fat synthesis, as previously described (Figure 2.2).  In 
studies by Dhiman et al. (2000) and Rego et al. (2009), diets supplemented with 
linseed oil (ALA) increased VA and RA content in milk fat while maintaining milk fat 
yield, whereas diets supplemented with soybean or sunflower oil (LA) caused a 
reduction in milk fat yield and the ‘trans-10 shift’ was observed; trans-10 18:1 and 
trans-10, cis-12 CLA increased with a corresponding decrease in milk fat content of 
VA and RA.  Additionally, linseed oil has the potential to increase n-3 FA in milk fat.  
Recent investigations supplementing linseed/flaxseed have shown to increase ALA 
content by ~ 2- 3-fold (Gonthier et al., 2005; Loor et al., 2005b; Flowers et al., 2008; 
Chilliard et al., 2009).  However, the beneficial effects of n-3 FA relate to the long 
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chain derivatives, EPA and DHA found predominantly in fish oil.  These FA are more 
difficult to increase in milk fat because they are extensively biohydrogenated in the 
rumen (Jensen, 2002; Lock and Bauman, 2004; Chilliard et al., 2007). 
Dietary supplements of fish oil have the potential to enhance milk fat CLA and 
n-3 content.  In addition to providing a dietary source of VLC n-3 PUFA, fish oil 
inhibits the final step of biohydrogenation from VA to stearic acid, thus allowing 
accumulation of VA for endogenous synthesis to CLA in the mammary gland 
(Chilliard, 2003; Figure 2.1).  However, fish oil is also a potent inducer of MFD and 
titration studies have examined the effect of different levels of supplementation on 
performance and milk composition variables (Donovan et al., 2000; Palmquist and 
Griinari, 2006; Whitlock et al., 2006).  Milk fat production decreased linearly with 
increased fish oil supplementation (1, 2, and 3% of total DM intake), while markedly 
increasing milk fat content of CLA, VA, EPA and DHA (Donovan et al., 2000).  Offer 
et al. (1999) and Whitlock et al. (2002) fed cows supplementary fish or plant oil 
(linseed or extruded soybeans, respectively) and reported that in comparison to plant 
oils, fish oil markedly reduced milk fat production while increasing VA, CLA, EPA, 
and DHA content in milk fat.  However, when the quantity of fish oil was lowered to 
<1% DM, with extruded soybean oil providing the remaining 2% total supplemented 
fat, there was no effect on milk fat yield, yet the increases in bioactive FA content of 
milk fat remained (Whitlock et al., 2006).  Furthermore, a synergistic effect was 
observed when minimal amounts of fish meal and extruded soybeans were 
supplemented, resulting in a greater increase of VA and CLA than when fed separately 
(AbuGhazaleh et al., 2002; Whitlock et al., 2002).  This effect is most likely due to the 
fact that plant oils provide the PUFA precursors of CLA, and when combined with 
low levels of fish oil, a greater increase of VA outflow from the rumen is possible 
(Loor et al., 2005b). 
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Table 2.3.   Dietary factors that affect concentrations of milk fat conjugated linoleic 
acid (CLA) 
 
Dietary factor Milk fat CLA content 
Forage  
     Pasture vs. corn silage Increases with fresh pasture 
     Pasture quality Decreases with maturity 
     Low fiber diets Increase 
Lipid supplement  
     Raw seeds Minimal increase 
     Processed seeds Increase 
     Plant oils Increase 
     Marine oils Marked increase 
Lipid composition  
     Saturated No effect 
     Unsaturated Increase 
     Linoleic acid, 18:2 n-6 Increase 
     Linolenic acid, 18:3 n-6 Increase 
Level of lipid supplementation Dose-dependent increase 
Adapted from Chilliard et al., 2000 and Jensen, 2002 
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Milk FA composition is highly influenced by dietary formulation and lipid 
supplementation.  While variation in milk fat CLA content is several-fold among 
individual cows, the most effective method to sustain an enhanced CLA or n-3 FA 
content in milk fat is through the inclusion of dietary lipid supplements.  Dietary 
factors influencing milk fat CLA content are reviewed in Table 2.3, and Chapters 4, 5, 
and 6 represent original research projects investigating the effects of dietary variables 
on the concentration of bioactive FA in milk fat.  Among the extensive number of 
investigations developing feeding strategies to enhance bioactive FA in milk fat, none 
have effectively sustained milk fat CLA or n-3 FA to a level that is physiologically 
effective while avoiding the potential economic loss from reduced milk fat production. 
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CHAPTER 3 
 
SURVEY OF THE FATTY ACID COMPOSITION OF RETAIL MILK IN THE 
UNITED STATES INCLUDING REGIONAL AND SEASONAL VARIATIONS 
 
INTRODUCTION 
 
Milk and dairy products are recognized as important sources of nutrients in 
human diets, providing energy, protein and a wide variety of essential amino acids, 
vitamins and minerals (Huth et al., 2006).  The composition of milk fatty acids (FA) is 
of interest for human dietary considerations, as consumers and health professionals are 
increasingly aware that fat and specific FA can affect human health and the prevention 
of chronic and acute diseases.  Milk fat contains a variety of saturated, trans and 
bioactive FA, some of which are included on food nutrition labels or product 
packaging.  In addition, milk fat is responsible for many of the sensory and physical 
properties of milk and the FA composition can impact the manufacturing properties 
during the production of dairy foods, such as cheese, butter and yogurt (Kaylegian et 
al., 1993; Palmquist et al., 1993).  
Assessment of dietary intake is an important tool in monitoring the nutritional 
status of the U.S. population and this includes the intake of fat and FA (Ervin et al., 
2004).  Since the last survey of U.S. commingled milk supply in 1984 (Barbano, 
1990), there have been a number of changes in industry practices that may impact the 
FA composition of milk fat (Palmquist et al., 1993; Jensen, 2002; Chilliard et al., 
2007).  The use of TMR and dietary lipid supplements have become common place, 
and by-products from the human food and fiber industry are routinely used in least 
cost ration formulations and these vary in fat content and FA composition.  In 
 39 
addition, analytical procedures for lipid analysis have improved, allowing greater 
detail of the FA profile.  Jensen (1999) emphasized it was “important to know the fatty 
acid profiles of dairy foods in the U.S.” and concluded “we cannot make reliable 
recommendations about the health aspects of milk fat unless we know the kinds and 
amounts of fatty acids therein.”  In a review, Jensen (2002) provided related 
information by summarizing the composition of bovine milk lipids from scientific 
papers published between January 1995 to December 2000.  However, these 
publications represent results from experimental treatments rather than reflecting the 
FA composition of retail dairy products.   Hence, our objective was to survey the FA 
composition of U.S. fluid milk supply and provide an updated FA profile of retail 
milk.  We were also interested in possible seasonal and regional effects on the FA 
composition and these were included in our experimental design. 
 
MATERIALS AND METHODS 
 
Sampling methods 
Whole fluid milk samples were obtained from 56 milk processing plants across 
the contiguous 48 United States.  All milk samples were homogenized, pasteurized 
and packaged for transport to retail stores.  Milk samples were conventionally 
produced; UHT milk and specialty labeled milk, such as ‘rbST-free’ or ‘organic,’ were 
excluded to minimize production variation.  Processing plants were selected based on 
the criteria that they represented at least 50% of the volume of milk produced in that 
area, and samples were obtained from each plant every 3 months during 2008 to 
capture seasonal variation.  Milk was shipped on ice overnight to Cornell University 
and immediately processed for the analysis of FA composition.   
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Fatty acid analysis 
Extraction of milk fat was based on the Mojonnier method (AOAC 995.19) as 
modified by Barbano et al. (1988). Briefly, milk fat was obtained from 10 ml whole 
fluid milk by a sequence of 3 successive extractions.  The first involved the addition of 
10 ml of 95% alcohol and 25 ml ethyl ether followed by vigorous mixing, the addition 
of 25 ml petroleum ether followed by vigorous mixing, and then decanting of the ether 
layer.  The second and third extractions were similar except the volume of solvents 
reduced to 5 ml of 95% alcohol and 15 ml each of ethyl and petroleum ethers, and the 
third extraction omitted the 95% alcohol.  Ether solutions from the 3 extractions were 
combined, dried and re-suspended in hexane.  Methyl esters of the extracted fat were 
prepared using sodium methoxide as the methylation reagent, according to Christie 
(1982) as modified by Chouinard (1999).  FA methyl esters were quantified by gas 
chromatography (Hewlett Packard GCD system HP 6890+, Hewlett-Packard, 
Avondale, PA) utilizing a CP-Sil 88 capillary column (100 m x 0.25 mm i.d. with 0.2 
µm film thickness; Varian Instruments, Walnut Creek, CA).  The initial oven 
temperature was set at 80°C and increased to 190°C at 2°C/min and maintained for 15 
min.  FA peaks were identified and recoveries quantified using pure methyl ester 
standards (GLC-569; NuChek Prep, Elysian, MN).  In addition, a butter oil reference 
standard (CRM 164; Commission of the European Communities, Community Bureau 
of Reference, Brussels, Belgium) was periodically analyzed as a control to verify 
column performance and correction factors for individual FA. 
 
Statistical analysis 
 The FA profile of milk samples (n = 228) was used for statistical analysis.  
Data were analyzed using JMP 7.0 (SAS Institute Inc., Cary, NC); geographic region 
(Pacific, n = 12; Southwest, n = 13; Southeast, n = 5; Northeast, n = 8; Central, n = 
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19), season (February, May, October, December) and their interaction were included 
in the model as fixed effects, and plant nested in region as a random effect.  Means 
and SEM are reported, and significance declared when P < 0.05.  For regional and 
seasonal effects, least-squares means and SEM are illustrated in figures.  
 
RESULTS AND DISCUSSION 
 
The FA composition summarized over all milk samples is presented in Table 
3.1. There were statistically significant differences for geographical region and season 
for individual FA; however, differences were minor and the overall SE ranged from 
0.1 to 0.7% of the mean value for individual FA (Table 3.1).  Thus, the overall FA 
composition was numerically similar for all regions and seasons, and the minor 
differences have little or no physiological or public health importance. 
Across all the samples, saturated fatty acids (SFA) comprised 63.7 ± 0.09% of 
total milk FA (mean ± SE), and this is nearly identical to values reported from the 
1984 survey (63.8%; calculated from Palmquist et al., 1993).  Averages for SFA were 
similar among regions and across seasons, and when statistically significant 
differences did occur they were of a very small magnitude (Figure 3.1).  These results 
contrast with the wide seasonal variation observed in SFA of milk fat in samples from 
Dutch dairy plants.  Heck et al. (2009) reported that SFA ranged from about 73-74% 
of total milk FA in winter samples to 68-69% in summer samples, and attributed the 
variation to the marked differences in the diets of the cows between the two seasons.   
The public health interest in SFA relates to the positive correlation between 
dietary SFA and cardiovascular disease (CVD) (Lichtenstein et al., 2006).  Whereas 
4:0, 6:0, 8:0, 10:0 and 18:0 are considered neutral, lauric acid (12:0), myristic acid  
(14:0) and palmitic acid (16:0) are considered an atherogenic risk because they 
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Table 3.1.   Fatty acid (FA) composition of retail milk samples in the United States 
 
   Effect, P-Value1 
Variable, g/100g FA Mean SD Region Season Interaction 
C4:0 4.15 0.26 NS <0.001 NS 
C6:0 2.13 0.11 <0.001 <0.001 NS 
C8:0 1.19 0.09 <0.001 <0.001 0.01 
C10:0 2.59 0.23 <0.001 <0.001 0.005 
C12:0 2.87 0.27 <0.001 <0.001 0.005 
C14:0 9.53 0.58 <0.001 <0.001 0.01 
C14:1 0.82 0.11 <0.001 <0.001 0.01 
C15:0 0.89 0.06 <0.001 <0.001 NS 
C16:0 28.08 1.15 <0.001 <0.001 <0.001 
C16:1 1.48 0.16 <0.001 <0.001 0.005 
C17:0 0.52 0.03 0.005 <0.001 0.005 
C18:0 11.68 1.15 <0.001 <0.001 0.005 
C18:1, t6 0.32 0.04 <0.001 <0.001 NS 
C18:1, t9 0.29 0.03 <0.001 0.005 0.01 
C18:1, t10 0.55 0.11 0.005 NS 0.01 
C18:1, t11 1.48 0.21 <0.001 NS 0.001 
C18:1, t12 0.54 0.07 <0.001 <0.001 <0.001 
C18:1, c9 23.58 1.10 <0.001 <0.001 NS 
C18:2, c9, c12 3.19 0.29 <0.001 0.005 0.001 
C20:0 0.09 0.01 <0.001 <0.001 NS 
C18:3 0.38 0.06 <0.001 NS NS 
C18:2, c9, t11 0.55 0.07 0.01 0.005 0.01 
C18:2, t10, c12 ND - - - - 
Other 3.09 0.31 NS <0.001 NS 
 
1Probability of statistical significant differences among corresponding regions, seasons 
and their interaction.  P > 0.05 is reported NS. 
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increase plasma concentrations of low-density lipoprotein cholesterol (Kris-Etherton 
and Yu, 1997).  However, these specific FA also increase plasma concentration of 
high-density lipoprotein cholesterol and this is indicative of a reduced risk for CVD.  
Mensink et al. (2003) conducted a meta-analysis of the effects of different FA using 
data from 60 clinical studies and expressed changes on the basis of the ratio of total 
cholesterol to high-density lipoprotein cholesterol; the ratios for 12:0, 14:0 and 16:0 
provided no support that these FA represented an atherogenic risk when compared to 
an isoenergenic substitution with carbohydrate.  Furthermore, a number of recent data 
summaries and large-scale clinical investigations have challenged the overall concept 
of saturated fat intake as a risk factor for CVD (Hooper et al., 2001; Taubes, 2001; 
Howard et al., 2006; Mente et al., 2009).  Likewise, recent studies have failed to show 
any relationship between the intake of dairy products and a risk for CVD (Elwood et 
al., 2004; German et al., 2009; Parodi, 2009). 
Monounsaturated FA (MUFA) represented 29.1 ± 0.08% of total milk FA 
(mean ± SE), and this was comparable to the value observed in 1984 (33.5%; 
calculated from Palmquist et al., 1993).  As with the SFA, averages were very similar 
for different geographic regions and across seasons, although there were small 
statistical differences (Figure 3.1).  Oleic acid was the predominant MUFA (23.6 ± 
0.08% of total milk FA; mean ± SE) (Table 3.1), and it is also the primary FA in 
Mediterranean diets based on olive oil.  Diets having a greater content of MUFA are 
associated with the prevention of CVD as reviewed by López-Miranda et al. (2006), 
and a meta-analysis of 60 controlled clinical studies demonstrated that intake of oleic 
acid was positively associated with a reduction in the risk for CVD based on effects on 
plasma cholesterol biomarkers (Mensink et al. 2003).  Generally, the dietary intake of 
oleic acid by ruminants is low and would be extensively biohydrogenated in the 
rumen.  Thus, the oleic acid in milk fat comes predominantly from ∆9-desaturase 
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B. 
 
 
Figure 3.1.  Fatty acid composition of saturated (SFA), monounsaturated (MUFA) 
and polyunsaturated (PUFA) fatty acids in retail milk samples by region (A) and 
season (B) in the United States.  SD bars are reported, but in some cases were too 
small to show properly.  Mean bars with different letters are different within each FA 
(P<0.05). 
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action on stearic acid (Chilliard et al., 2000).  This enzyme is also responsible for the 
production of other MUFA in milk fat that have a cis-9 double bond, such as 
myristoleic acid (14:1) and palmitoleic acid (16:1). 
Polyunsaturated fatty acids (PUFA) are considered beneficial to human health 
and represented 4.1 ± 0.02% of total milk FA (mean ± SE), which is greater than the 
value reported in 1984 (2.8% PUFA in total milk FA). However, it is important to note 
that analytical techniques were not as advanced to identify 18:3 unsaturated FA or 
longer chain FA.  This would likely result in an under-reporting of PUFA and a 
corresponding overestimation of the proportion of SFA and MUFA in 1984 values.  
Nevertheless, linoleic acid (18:2) was the predominant PUFA isomer at 3.1% of total 
milk FA and this is similar to the PUFA value from 1984.  We observed no seasonal 
differences in the PUFA content of milk fat, but there were statistically significant 
differences of a very small magnitude among geographic regions (Figure 3.1). 
Trans FA (TFA) represented 3.2% of milk FA, and this value was not reported 
in the earlier 1984 study due to limitations in the analytical techniques that were used.  
However, Precht and Molkentin (1996) combined argentation thin-layer 
chromatography and gas-liquid chromatography to analyze TFA in the milk fat from 
Germany; this milk fat, derived by melting commercial butter from over 1700 
samples, had an average trans-18:1 FA content of 3.6% of total FA.  In the present 
study, vaccenic acid (trans-11 18:1) was the main positional isomer, representing 46.5 
± 0.22% of total TFA (mean ± SE) with trans-10 and trans-12 next at 17.4 ± 0.15% 
and 16.8 ± 0.08% of total TFA.  Vaccenic acid was also the major trans-18:1 isomer 
in the study by Precht and Molkentin (1996), averaging 47.5% of the total trans-18:1 
FA.    Regional and seasonal differences for the distribution of TFA isomers in the 
present study are illustrated in Figure 3.2; while there were some statistically 
significant differences, in all cases the differences were minor. 
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B. 
 
 
Figure 3.2.  Isomer distribution of the trans 18:1 fatty acids (FA) in retail milk 
samples by region (A) and season (B) in the United States.  SD bars are reported, but 
in some cases were too small to show properly.  Mean bars with different letters are 
different within each FA (P<0.05). 
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The TFA content of milk fat and the TFA isomer distribution can be markedly 
affected by diet (Chillliard et al., 2007).  The minor differences in the present study 
suggest that any diet variation among regions and across seasons must have had only 
very modest effects on rumen biohydrogenation.  Interestingly, Precht and Molkentin 
(1996) observed substantial shifts in TFA related to season that they attributed to diet; 
a greater total TFA content of milk fat and a higher proportion of trans-11 18:1 
occurred in ‘summer pasture feeding’ as compared to the ‘winter barn feeding.’  Heck 
et al (2009) reached similar conclusions in their study of the seasonal variation in the 
milk supply from Dutch dairy plants, as availability of pasture directly correlated with 
increases in trans-11 18:1 and other FA known to be affected by lush pasture grazing. 
The consumption of monounsaturated TFA has been associated with a greater 
risk of CVD (Mensink et al., 2003; Mozaffarian et al., 2006).  There are two dietary 
sources for TFA in food supply: industrial sources originating from the use of partially 
hydrogenated vegetable oils (PHVO) and natural sources that are found in ruminant-
derived food products.  The relationship between TFA intake and risk of CVD is based 
on industrial sources of TFA.  However, several data summaries of epidemiological 
data have demonstrated that naturally occurring TFA from ruminant-derived foods 
were not correlated to incidence of CVD (see reviews by Lock et al. (2005), Jakobsen 
et al. (2008), and Stender et al. (2008)).  This important distinction may be explained, 
at least in part, by differences in the trans isomer distribution.  Ruminant-derived TFA 
are primarily trans-11 18:1 while industrial TFA consist of a Gaussian distribution 
centered on trans-9 and trans-10 18:1.  Of the TFA, trans-11 18:1 has been 
extensively investigated for potential health benefits related to its conversion to the 
cis-9, trans-11 isomer of conjugated linoleic acid (CLA) (Bauman and Lock, 2006). 
The CLA content of milk fat is of special interest because in human diets it 
predominantly originates from ruminant milk and meat products (~95%).  When 
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consumed as a natural component of the diet, CLA has been shown to have potent 
anti-carcinogenic and anti-atherogenic effects in biomedical studies using animal 
models of human disease (see review by Bauman et al., 2006).  CLA is often 
expressed as mg/g FA and we found an average of 5.5 mg/g FA as the overall mean 
for the retail milk samples (Table 3.1).  Similar values were reported for milk samples 
from Dutch dairy plants (5.4 mg/g FA; Heck et al., 2009) and US specialty labeled 
retail milk samples (5.7 to 7.0 mg/g FA; Chapter 4).  Whereas we observed only very 
minor geographic or seasonal differences (Table 3.1), Precht and Molkentin (2000) 
observed the CLA content was about doubled in German retail samples obtained 
during ‘summer pasture feeding’ as compared to ‘winter barn feeding.’  The CLA 
content in bovine milk is affected by a number of physiological factors such as breed 
and stage of lactation, but the major factor is diet (Bauman and Lock, 2006; Chilliard 
et al., 2007).  Over the last decade, researchers have worked to develop methods to 
sustain an enhanced CLA content in milk fat to a value that may be physiologically 
effective, ~3- to 5- fold greater than the level reported in the current study (Bauman et 
al., 2006).  Recently, milk and meat foods have appeared on grocery shelves and 
restaurant menus with label claims of an enhanced CLA content.  Our results provide a 
formal baseline value for the current CLA content of U.S. retail milk. 
Omega-3 FA are also considered beneficial to human health for the prevention 
of chronic and acute diseases.  In milk fat, α-linolenic acid (ALA) is the predominant 
omega-3 FA and in the present study it was present at 0.38% of total milk FA.  Other 
studies with retail milk fat samples from Germany (0.68 g/100g FA) and the 
Netherlands (0.50 g/100g FA) and specialty labeled retail milk from U.S. (0.41 g/100g 
FA) have observed a similar low level of ALA in milk fat (Precht and Molkentin, 
2000; Heck et al., 2009; Chapter 4).  Longer chain omega-3 FA that are derived from 
ALA, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), were 
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present in minimal quantities and not reported in the current study.  The human health 
benefits from omega-3 FA relate to EPA and DHA and their involvement in the 
prevention of CVD and other chronic diseases (Yashodhara et al., 2009).  
Unfortunately, the ability to convert ALA to longer chain omega-3 FA is very limited 
in humans (Arterburn et al., 2006; Brenna et al., 2009) and cows (Hagemeister et al., 
1991).  Thus, the results from our analysis indicate that dairy products provide little 
contribution to the omega-3 FA requirement of humans because the omega-3 FA 
concentration in milk fat is very low and the particular isomer that is present (ALA) is 
poorly utilized for the synthesis of EPA and DHA.   
Diet is a major factor affecting the FA composition of milk fat.  Although 
feeding management systems and feed ingredients have changed in the last 25 years, 
milk FA composition was remarkably similar to milk in 1984.  Likewise, milk FA 
composition was relatively similar among geographic regions and across seasons, 
thereby implying that increased use of TMR, lipid supplements and by-product 
feeding must be well established in all regions and in routine use across all seasons.  
Some differences among individual farms would be expected, but the pooling of milk 
at the processing plant would dilute milk from farms implementing unique feeding or 
management practices. Our focus was on retail milk and for this reason we 
purposefully obtained processed and packaged milk samples to more accurately reflect 
milk available to the consumer. Improvements in analytical techniques and 
identification of CLA and trans FA have allowed for reporting of specific isomers of 
interest related to human health.  The present study provides an updated report of the 
FA composition of U.S. retail milk that can serve as a reference for estimating dietary 
intake of FA from dairy products and for future studies. 
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CHAPTER 4 
 
SURVEY OF THE FATTY ACID COMPOSITION OF RETAIL MILK 
DIFFERING IN LABEL CLAIMS BASED ON PRODUCTION 
MANAGEMENT PRACTICES 
 
INTRODUCTION 
 
Nutritional quality is an important consideration when making food choices.  
Milk is an excellent source of many essential nutrients and supplies the body with 
energy, high quality protein, and a variety of the required vitamins and minerals (Huth 
et al., 2006).  In addition, consumers are increasingly aware that some food 
components may have long-term effects on human health.  Fats are of special interest, 
and milk fat is considered a saturated fat because of its fatty acid (FA) profile.  Among 
the individual FA in milk fat, several such as omega-3 FA and conjugated linoleic 
acids (CLA) may have beneficial effects on health maintenance and the prevention of 
acute and chronic diseases (Lock and Bauman, 2004; Bauman et al., 2006; German 
and Dillard, 2006).  Dietary intake of others, such as some of the individual saturated 
fatty acids (eg. lauric, myristic, palmitic acids) and the trans-18:1 fatty acids (TFA) 
are considered risk factors in coronary heart disease (Lock et al., 2005; Parodi, 2009). 
In recent years, grocery stores have expanded their dairy case selection to 
include milk products with label claims related to agricultural management practices.  
In addition to conventionally produced milk, retail choices often include milk labeled 
as recombinant bST (rbST)-free and organic.  Consumers have little knowledge of 
how milk is produced, and the information search for most Americans rarely extends 
beyond package labeling and retail marketing.  Of particular concern, some consumers 
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may perceive that this type of specialty labeling indicates differences in the quality, 
nutritional value, or safety of dairy foods.  Vicini et al. (2008) recently conducted a 
survey that compared retail samples of conventional milk with milk labeled as rbST-
free or organic; they found that there were no meaningful differences in quality 
(antibiotics and bacterial counts), gross composition (fat, protein and solids-not-fat), 
or hormone concentrations (including bST, estrogen, and insulin-like growth factor-1) 
among the retail milk samples with these labels.  The milk fat content and fatty acid 
profile can be markedly affected by management practices, especially through ration 
formulation and use of specific dietary components (Palmquist et al., 1993; Chilliard 
et al., 2000; Jensen, 2002).  Our specific objective was to compare the fatty acid 
profile of conventional milk with retail milk samples labeled as rbST-free and organic.  
Bioactive FA such as omega-3 FA, CLA and TFA were of special interest as well as 
the overall profile and distribution of saturated and unsaturated fatty acids. 
 
MATERIALS AND METHODS 
 
Sampling methods 
 Milk samples used in the present investigation were those described for the 
study by Vicini et al. (2008).  Briefly, retail milk samples were obtained from stores 
within the 48 contiguous United States during a 3-wk period in October and 
November 2006, and purchased in blocks to minimize effects of shipping conditions.  
Blocks contained one each of the following label types: conventional, rbST-free, and 
organic milk.  Conventional milk samples were those that had no label claims 
regarding rbST use or production practices.  Milk labeled rbST-free included a label 
claim that cows were not supplemented with rbST, and milk labeled as organic 
originated from farms certified to meet USDA standards for organic production.  
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Purchasers were Monsanto Company employees residing in each state.  States 
producing larger volumes of milk or those with higher populations were over-sampled 
to more accurately represent the overall milk supply within the US, and samples were 
selected with the following considerations: 1) whole milk for fat analysis; 2) freshest 
milk based on expiration date; and 3) paper or plastic container.  Unpasteurized milk 
and milk labeled as using UHT pasteurization were excluded to minimize processing 
differences among samples.  Further details on sampling and storage are given in an 
earlier publication (Vicini et al., 2008).  For the present study, sample aliquots were 
shipped frozen overnight to Cornell University and stored frozen at -20°C until 
processed for FA analysis.   
 
Fatty acid analysis 
 Extraction of milk fat was based on the method of Hara and Radin (1978) and 
transmethylation of the esterified FA was according to Christie (1982) as modified by 
Chouinard (1999).  Briefly, hexane:isopropanol was used to extract the milk fat and 
sodium methoxide served as the methylation reagent. FA methyl esters were 
quantified by gas chromatography (Hewlett Packard GCD system HP 6890+, Hewlett-
Packard, Avondale, PA) fitted with a CP-Sil 88 fused-silica capillary column (100 m x 
0.25 mm i.d. with 0.2 µm film thickness; Varian Instruments, Walnut Creek, CA).  
The initial oven temperature was set at 80°C and increased to 190°C at 2°C/min and 
maintained for 20 min, then increased to 225°C at 10°C/min and maintained for 12 
min.  FA peaks were identified and recoveries quantified using pure methyl ester 
standards (GLC-569; NuChek Prep, Elysian, MN).  In addition, a butter oil reference 
standard (CRM 164; Commission of the European Communities, Community Bureau 
of Reference, Brussels, Belgium) was periodically analyzed as a control to verify 
column performance and correction factors for individual FA. 
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Statistical analysis 
 The FA composition of the milk samples (n = 292) was used for statistical 
analysis.  Data were analyzed using JMP 7.0 (SAS Institute Inc., Cary, NC); treatment 
groups (conventional (n = 111), rbST-free (n = 82), and organic (n = 99) labeled milk) 
were included in the model as a fixed effect and shipping block (n = 123) as a random 
effect.  Least-squares means were reported using Tukey’s test for detecting differences 
between treatment means, and significance declared when P < 0.05.  For some FA, 
variances were declared unequal by Levene’s test and thus analyzed using SAS 9.0 
(SAS Institute Inc., Cary, NC) to allow for unequal variances and report individual 
variance estimates for each treatment group.  Significance was declared when P < 
0.05. 
 
RESULTS AND DISCUSSION 
 
In an effort to increase market share and offer choice to consumers, the dairy 
case often carries milk with specialty labels based on production practices.  In the 
present study, we compared the FA composition of conventional milk containing no 
specialty labeling with retail milk samples labeled as ‘rbST-free’ or ‘organic’.  rbST is 
a biotechnology product that regulates nutrient partitioning in lactating cows 
(Bauman, 1999).  Its administration increases milk production and improves efficiency 
so feed resource input, animal waste output, and environmental impact per unit of 
milk are reduced (National Research Council, 1994; Capper et al., 2008).  Since FDA 
approval for commercial use in 1993, over 30 million U.S. cows have received rbST 
supplements, but there is no test or milk difference that can detect rbST use.  Thus, the 
rbST-free label is based on a farmer affidavit indicating that this supplement was not 
used.  Milk that is labeled organic comes from dairy farms that have been certified as 
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following production practices for livestock as outlined in the USDA Organic 
Standards (USDA/Agricultural Marketing Service, 2009).  These include production 
management practices such as no use of antibiotics for the treatment of sick animals, 
no use of pesticides in the production of feedstuffs, and no use of particular 
management technologies including transgenic products such as rbST or genetically 
modified crops.  As with rbST-free milk, there is no test that can differentiate organic 
milk, thus verification is enforced by a third party certification system. 
Milk FA profiles were remarkably similar among label types (Table 4.1).  
Conventional and rbST-free milk were not statistically different, thus for discussion 
purposes, values presented in the text represent an average of these two milk types 
compared to organic milk.  Milk labeled as organic was significantly higher in 
saturated fatty acids (SFA) (65.9% vs 62.8%; P < 0.001) and lower in 
monounsaturated fatty acids (MUFA) (26.8% vs 29.7%; P < 0.001) and 
polyunsaturated fatty acids (PUFA) (4.3% vs 4.8%; P < 0.001) as compared to 
conventional and rbST-free milk (Figure 4.1).  This pattern is less desirable from a 
public health perspective, but the differences were relatively minor.  Among the TFA 
isomers, trans-11 18:1 predominated for all milk types, and its concentration was 
greater in milk labeled organic as compared to conventional and rbST-free milk 
samples (1.71% vs 1.46%; P < 0.001)  (Figure 4.2).  In contrast, the opposite was true 
for trans-10 18:1.  While variation in trans-10 18:1 supply within the physiological 
range has no direct effect on milk fat synthesis (Lock et al., 2007), it is associated with 
alterations in rumen biohydrogenation of dietary PUFA that are characteristic of diet-
induced milk fat depression (Harvatine et al., 2009).  Thus, increases in trans-10 18:1 
content of milk fat are correlated with reductions in the de novo synthesized FA (4:0 to 
16:0) that represent the bulk of the SFA content of milk fat (Shingfield and Griinari, 
2007; Harvatine et al., 2009).  In the present study we saw a pattern consistent with 
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Table 4.1.  Fatty acid composition of retail milk samples with labels representing 
different production management practices 
 
 Treatment1  
Variable Conventional rbST-free Organic P-value2 
 ---Percent of total fatty acids---- 
C4:0 4.17 ± 0.03b 4.22 ± 0.03b 4.36 ± 0.03a <0.001 
C6:0 2.12 ± 0.01b 2.11 ± 0.01b 2.30 ± 0.01a <0.001 
C8:0 1.15 ± 0.01b 1.13 ± 0.01b 1.26 ± 0.01a <0.001 
C10:0 2.53 ± 0.02b 2.49 ± 0.02b 2.81 ± 0.02a <0.001 
C12:0 2.89 ± 0.03b 2.83 ± 0.02b 3.24 ± 0.03a <0.001 
C14:0 9.63 ± 0.06b 9.42 ± 0.05c 10.62 ± 0.06a <0.001 
C14:1, c9 0.89 ± 0.01b 0.87 ± 0.01b 0.98 ± 0.01a <0.001 
C15:0 0.90 ± 0.01b 0.87 ± 0.01c 1.07 ± 0.01a <0.001 
C16:0 27.99 ± 0.13b 27.78 ± 0.09b 29.27 ± 0.17a <0.001 
C16:1, c9 1.55 ± 0.02a 1.53 ± 0.01a 1.47 ± 0.02b 0.0030 
C17:0 0.50 ± <0.01b 0.50 ± <0.01b 0.55 ± <0.01a <0.001 
C18:0 10.88 ± 0.10a 11.04 ± 0.08a 10.21 ± 0.12b <0.001 
C18:1, t6-8 0.29 ± 0.01a 0.30 ± <0.01a 0.22 ± <0.01b <0.001 
C18:1, t9 0.28 ± <0.01a 0.29 ± <0.01a 0.21 ± <0.01b <0.001 
C18:1, t10 0.52 ± 0.02a 0.55 ± 0.01a 0.28 ± 0.01b <0.001 
C18:1, t11 1.45 ± 0.02b 1.47 ± 0.02b 1.71 ± 0.05a <0.001 
C18:1, t12 0.50 ± 0.01a 0.52 ± 0.01a 0.38 ± 0.01b <0.001 
C18:1, c9 23.90 ± 0.14b 24.38 ± 0.09a 21.44 ± 0.11c <0.001 
C18:2, n-6 3.50 ± 0.06a 3.43 ± 0.04a 2.55 ± 0.08b <0.001 
C20:0 0.09 ± <0.01b 0.09 ± <0.01b 0.10 ± <0.01a <0.001 
C18:3, n-3 0.41 ± 0.01b 0.40 ± 0.01b 0.65 ± 0.01a <0.001 
C18:2, c9, t11 0.57 ± 0.01b 0.57 ± 0.01b 0.70 ± 0.02a <0.001 
20:4, n-6 0.14 ± <0.01a 0.14 ± <0.01a 0.11 ± <0.01b <0.001 
20:5, n-3 0.03 ± <0.01b 0.03 ± <0.01b 0.06 ± <0.01a <0.001 
22:5, n-3 0.06 ± <0.01b 0.06 ± <0.01b 0.11 ± <0.01a <0.001 
22:6, n-3 ND ND ND - 
Other 2.95 ± 0.04b 2.94 ± 0.03b 3.17 ± 0.03a <0.001 
 
1Treatment groups were conventional milk samples (no label claims regarding 
production management practices) and retail milk samples labeled as rbST-free and 
organic.  Values represent least squares means ± SE for retail milk samples (n = 292). 
ND indicates not detected (< 0.01 percent of total fatty acids). 
2Probability of significant differences among treatment groups.  Within a row 
differences are indicated by different superscript letters. 
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Figure 4.1.  Fatty acid composition of conventional milk samples and retail milk 
samples labeled as recombinant bST (rbST)-free and organic.  Bar graphs are coded 
for conventional (black), rbST-free (speckled) and organic (grey) milk with grouping 
representing saturated fatty acids (SFA), monounsaturated fatty acids (MUFA) and 
polyunsaturated fatty acids (PUFA).  SE for each treatment bar were too small to show 
properly, but expressed as a percent of total fatty acids were <0.22 for SFA, <0.20 for 
MUFA and <0.07 for PUFA. 
 
 
Figure 4.2.  Fatty acid composition for the trans 18:1 isomers in conventional milk 
samples and retail milk samples labeled as recombinant bST (rbST)-free and organic.  
Bar graphs are coded for conventional (black), rbST-free (speckled) and organic 
(grey) milk.  SE bars for some treatment groups were too small to show properly, but 
all were <0.01 of total fatty acids.  
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this where the milk fat content of trans-10 18:1 was greater and concentrations of FA 
chain length 4:0 to 16:0 carbons and total SFA were lower in the milk fat from 
conventional and rbST-free milk samples as compared to the organic samples.  
However, for all SFA and TFA, differences in milk fat content among label types were 
minor and of no physiological importance when considering public health or dietary 
recommendations. 
SFA and TFA are considered detrimental to human health because these FA 
have been associated with a higher risk of cardiovascular disease (CVD) (National 
Research Council, 1989; USDHHS/USDA, 2005); to a large extent, the content of 
SFA and TFA in milk fat is the basis for the perception that milk and dairy products 
are associated with a higher risk of CVD.  However, recent epidemiological studies 
and dietary intervention trials challenge this perception, and available evidence does 
not support the concept that consumption of dairy products represents an increased 
risk of CVD (Elwood et al., 2004; German et al., 2009; Parodi, 2009).  Furthermore, 
12:0, 14:0 and 16:0 are specific SFA that increase plasma low-density lipoprotein 
(LDL)-cholesterol levels, a plasma cholesterol fraction associated with increased risk 
of CVD (Mensink et al., 2003); retail milk labeled organic had higher concentrations 
of these FA compared to conventional and rbST-free milks (43.1 vs 40.3% of total 
milk FA; P < 0.0001).  However, these specific FA also increase plasma high-density 
lipoprotein (HDL)-cholesterol, a plasma fraction associated with lower risk of CVD, 
thus partially offsetting the negative effect of increased LDL-cholesterol (Mensink et 
al., 2003; Parodi, 2009).  A meta-analysis of the effects of these FA using data from 
60 clinical studies demonstrated that the plasma ratio of total cholesterol:HDL-
cholesterol provided little evidence that dietary intake of 12:0, 14:0 and 16:0 
represented an atherogenic risk when compared to an isocaloric substitution of 
carbohydrate (Mensink et al., 2003).  
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Human dietary intake of TFA is ~80% from industrial sources due to the use of 
partially hydrogenated vegetable oils in baking, margarine and manufacturing of other 
foods (http://vm.cfsan.fda.gov/~dms/qatrans2.html).  The remaining 20% comes from 
natural sources represented by dietary intake of dairy products and meat from 
ruminants.  Industrial and natural sources differ in isomer distribution of 18:1 TFA; 
the TFA in partially hydrogenated vegetable oil has a Gaussian distribution of isomers 
centering on trans-9 and trans-10 18:1 (Lock et al., 2005; Destaillats et al., 2008).  In 
contrast, natural TFA consist mainly of trans-11 18:1.  In the present study, 18:1 TFA 
represented 2.8% of total FA in the milk fat from organic samples, of which 61.1% 
was trans-11 18:1; similar values for conventional and rbST-free milk averaged 3.1% 
and 47.4%, respectively (Table 4.1).  However, the CVD health concern from 
consumption of TFA is associated with industrial sources.  A plot of the data from 
published epidemiological studies demonstrates an increased risk of CVD with 
increasing dietary intake of industrial TFA (Lock et al., 2005).  In contrast, this is not 
observed for natural sources of TFA and to date, there is no scientific evidence to 
indicate that naturally occurring TFA are detrimental to human health (see reviews by 
Jakobsen et al. (2008) and Stender et al. (2008)).  Nevertheless, trans fats and SFA are 
included on food labels due to concerns about their potential health effects.   
Conjugated linoleic acid (cis-9, trans-11 18:2 CLA) is a bioactive FA present 
in milk fat that has anticarcinogenic and antiatherogenic effects (Bauman et al., 2006).  
CLA is formed as an intermediate in rumen biohydrogenation of dietary PUFA; 
however, the majority of CLA in milk fat is endogenously synthesized in the 
mammary gland by ∆9-desaturase with the substrate being trans-11 18:1, another 
rumen biohydrogenation intermediate (Bauman and Lock, 2006).  In the present study, 
CLA was greater in milk labeled organic as compared to conventional and rbST-free 
labeled milk (Table 4.1).  However, the average CLA content was relatively low for 
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all label groups (5.7 to 7.0 mg CLA/g FA) and differences among milk sources were 
relatively minor, having little or no implications for human health. 
The benefits of CLA in health maintenance and the prevention of chronic 
diseases have been established in biomedical studies with animal models; 
extrapolation of CLA doses from these studies indicates that the benefits would occur 
if the CLA content of milk fat was at levels 4- to 6-fold greater than that observed for 
all retail samples in the present study (Parodi, 2003; Bauman et al., 2006).  The CLA 
content of milk fat can be markedly effected by diet and this probably is the reason for 
the variation among milk samples within label groups, especially for the organic group 
(Figure 4.3).  Organic producers are required to provide cows access to pasture, and 
pasture is a dietary component that may increase milk fat content of CLA.  However, 
this effect is most pronounced when cows are grazing lush pasture, and effects are 
mitigated as the pasture matures or the diet includes additional feedstuffs (Kelly el al., 
1998b; Auldist et al., 2002).   
Omega-3 FA are essential for optimal health and the prevention of chronic and 
acute diseases (Yashodhara et al., 2009).  In milk, α-linolenic acid (ALA) is the 
predominant omega-3 FA and it was at a greater concentration in milk labeled organic 
as compared to conventional and rbST-free milk (0.65% vs 0.41%, respectively; Table 
4.1).  However, these concentrations are very low and represent a minimal 
contribution to the dietary requirement of humans (Kris-Etherton et al., 2009).  
Furthermore, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the 
omega-3 FA that are important in health maintenance and the prevention of chronic 
and acute diseases (Lavie et al., 2009; Yashodhara et al., 2009).  Human clinical 
studies have shown that the conversion of ALA to EPA or DHA is very limited in 
adults and children (Arterburn et al., 2006; Brenna et al., 2009); therefore, the dietary 
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Figure 4.3.   Range of variation for conjugated linoleic acid (CLA) and omega-3 fatty 
acids among conventional milk samples and retail milk samples labeled as 
recombinant bST (rbST)-free and organic. Box plots display the median (middle line), 
with the 75th and 25th quartiles above and below (distance between these is the 
interquartile range).  The top and bottom lines represent upper quartile + 1.5 
interquartile range and lower quartile – 1.5 interquartile range. 
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recommendation for adult humans is 500 mg/d for EPA + DHA, irrespective of ALA 
consumption (Gebauer et al., 2006; Kris-Etherton et al., 2009).   
Previous studies from other countries have compared the CLA and omega-3 
FA content of organic and conventional milk.  These have typically involved 
comparisons of individual farms and often only small sample sizes; none have 
examined labeled retail milk in a manner comparable to the present study.  Some of 
these investigations have reported greater CLA content in milk from organic farms 
(Bergamo et al., 2003; Kraft et al., 2003), while others report differences in omega-3 
FA but not in the CLA content of milk fat (Ellis et al., 2006; Butler et al., 2008; 
Molkentin, 2009).  These inconsistent results are most likely related to the use of milk 
from controlled, farm-level experiments rather than retail milk that would represent 
pooled milk as purchased by consumers.  In practice, organic farms as well as 
conventional farms can vary widely in feeding and diet formulations.  This variation 
was clearly demonstrated in a study by Molkentin (2009) who compared the omega-3 
FA milk fat content from three retail sources of organic and conventional milk, as well 
as one individual organic farm on a biweekly basis for 18 mo.  The individual organic 
farm had the highest and lowest omega-3 FA value as compared to the organic retail 
samples over the duration of the study, illustrating the substantial variation that exists 
with single-farm sampling.  The variation observed in the present study for omega-3 
and CLA content of milk fat in retail samples is also likely due to diet differences 
(Figure 4.3).  Nevertheless, across all farm or retail based studies that have compared 
organic with conventional milks, any differences that were observed in FA 
composition were small and not of magnitude to have human health implications.  
 The present study is among the first to investigate differences in the fatty acid 
profile of specialty labeled retail milk samples.  Milk labeled rbST-free was not 
statistically different from conventional milk, but there were statistical differences 
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between milk labeled organic and the conventional and rbST-free retail samples.  
Some of these differences could be considered desirable and some less desirable, but 
without exception differences among conventional milk and milk labeled as rbST-free 
or organic were minor and unlikely to be of public health relevance.  Milk FA profile 
is mainly affected by dietary components and formulations rather than production 
management practices.  It is possible to use common feedstuffs to achieve a CLA 
content in milk fat that may aid in the prevention of chronic diseases, especially when 
total mixed rations are supplemented with plant or fish oils that are high in PUFA (see 
reviews by Chilliard et al. (2000) and Bauman and Lock (2006)).  Likewise, the milk 
fat content of very long chain omega-3 PUFA can be enriched by feeding cows 
supplements of fish oil, algae or other marine products containing EPA and DHA or 
dietary supplements containing stearidonic acid (C18:4, n-3) (Chapter 7; Palmquist, 
2009).  Interestingly, increasing the CLA content of milk fat requires an incomplete 
rumen biohydrogenation of PUFA whereas increasing the omega-3 content requires 
protection of the very long chain PUFA to avoid biohydrogenation.  Overall, results 
from the present study comparing the FA composition from conventional retail milk 
and milk labeled rbST-free or organic found no meaningful differences that would 
impact public health.  When FA data are combined with previous analyses of these 
samples (Vicini et al., 2008), results indicate that these specialty milks are similar in 
nutritional quality and wholesomeness. 
 63 
CHAPTER 5 
 
EFFECT OF LINOLEIC ACID AND DIETARY VITAMIN E 
SUPPLEMENTATION ON SUSTAINED CONJUGATED LINOLEIC ACID 
PRODUCTION IN MILK FAT FROM DAIRY COWS 
 
INTRODUCTION 
 
Consumers are increasingly aware of the link between diet and health, and 
recently fatty acids (FA) have gained special attention for their potential health 
benefits.  Conjugated linoleic acid (CLA) is one such bioactive FA that may function 
to improve health maintenance and prevent chronic diseases.  When consumed as a 
natural component of the diet, cis-9, trans-11 18:2 CLA (rumenic acid; RA) has been 
consistently shown to offer anti-carcinogenic and anti-atherogenic effects in 
biomedical studies using animal models of human disease (Parodi, 2004; Bauman et 
al., 2006b).  The presence of RA in human diets originates almost exclusively from 
ruminant-derived milk and meat products (Ritzenthaler et al., 2001).  Rumen 
microbial biohydrogenation of polyunsaturated fatty acids (PUFA) produces RA and 
trans-11 18:1 (vaccenic acid; VA) as intermediates (Palmquist et al., 2005).  Although 
some RA escapes from the rumen prior to complete saturation, the major source of RA 
in milk fat is endogenous synthesis from VA via the mammary enzyme ∆-9 desaturase 
(Bauman and Lock, 2006). 
Environmental and physiological factors that affect the milk fat content of RA 
have been identified, with diet having the greatest effect (Chilliard et al., 2000; 
Palmquist et al., 2005).  Supplementing diets with plant oils high in PUFA is 
especially effective in enhancing milk fat content of RA.  However, increases in 
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dietary intake of PUFA may also alter the rumen environment resulting in a shift in 
the production and isomer profile of the CLA and trans FA intermediates produced 
during rumen biohydrogenation (Bauman and Griinari, 2003; Shingfield and Griinari, 
2007).  Referred to as the ‘isomerase shift’ or ‘trans-10 shift’ (Lock et al, 2008), 
additional CLA isomers are produced during biohydrogenation and these typically 
include trans-10, cis-12 which has been shown to inhibit milk fat synthesis and induce 
milk fat depression (MFD) (see review by Bauman et al., 2008). 
The ability to minimize risk of diet-induced MFD would have potential 
application and interest in many situations including the use of diets designed to 
achieve a sustained increase in milk fat content of CLA.  Diet-induced MFD results in 
a characteristic pattern of reduced percent and yield of milk fat, and a shift in the FA 
composition of milk fat (Bauman and Griinari, 2003; Harvatine et al., 2009).  Results 
from several recent investigations have suggested a possible role for vitamin E in 
preventing the shift in rumen biohydrogenation pathways and subsequent MFD 
(Charmley and Nicholson, 1994; Focant et al., 1998; Kay et al., 2005; Bell et al., 
2006; Pottier et al., 2006).  These studies supplemented cow diets with high levels of 
vitamin E, although in some cases study objectives were unrelated to maintaining milk 
fat yield.  Effects of vitamin E supplementation on variables characteristic of diet-
induced MFD were observed, but the pattern across variables was inconsistent.  
Furthermore, the studies varied in forage source, type of oil or oilseed supplements 
and use of TMR or pasture-based production systems.  Nevertheless, when considered 
as a group, results from these studies suggest a possible role for high doses of vitamin 
E (2,600 to 12,000 IU/d) in the maintenance of milk fat yield, and that vitamin E may 
act to reduce the risk of the trans-10 shift, thus minimizing any undesirable effects of 
plant oils on milk fat yield.  Therefore, our objective was to feed a typical 
Northeastern U.S. corn based-diet to dairy cows and investigate whether diets 
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supplemented with the combination of soybean oil and high levels of vitamin E would 
result in a sustained increase in the milk fat content of CLA while avoiding MFD.  
 
MATERIALS AND METHODS 
 
Animals and experimental design 
 All procedures involving dairy cows were approved by the Cornell University 
Institutional Animal Care and Use Committee.  Lactating Holstein cows (n = 32 
multiparous and 16 primiparous) were assigned to a completely randomized block 
design with repeated measures.  A 2 wk pretreatment period served as the covariate for 
baseline values followed by a 28 d treatment period where cows were fed one of four 
dietary treatment diets: 1) control (C), 2) control plus 10,000 IU/d vitamin E (E), 3) 
control plus 2.5% soybean oil (Oil), and 4) control plus 2.5% soybean oil plus 10,000 
IU/d vitamin E (Oil/E).  The basal diet consisted of 60:40 forage to concentrate ratio, 
with corn silage the major forage source (Table 5.1).  The oil supplement was fully 
mixed into the TMR and the vitamin E supplement (dl-α tocopheryl acetate; DSM 
Nutritional Products, Parsippany, NY) was top-dressed once daily when fresh feed 
was offered.    
Cows were housed in individual tie stalls at the Cornell University Teaching 
and Research Center (Harford, NY) and fed a basal TMR diet throughout the 
pretreatment and treatment periods.  The diet was formulated using the Cornell Net 
Carbohydrate and Protein System (Fox et al., 2004) to meet or exceed nutritional 
requirements (NRC, 2001).  Cows were fed for ad libitum intake allowing 10% 
refusals, with orts determined and fresh feed offered once daily.  Fresh feed samples 
were taken weekly, combined to form monthly composites, and dried at 50°C for 72 h 
for DM determination.  Composites were analyzed by wet chemistry procedures for 
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CP, ADF, NDF and ether extract (Table 5.1; Dairy One Cooperative Inc., Ithaca, NY).  
Fresh water was available at all times.  
 Cows were milked 3 times per day, and milk weights recorded.  Duplicate 
samples were collected from the last 2 d of the pretreatment period as well as the last 
2d of each week during the treatment period; one aliquot was stored with bronopol 
preservative at 4°C until mid-infrared analysis for fat, true protein, lactose and SCC 
(Method 972.160, AOAC, 2000; Dairy One Cooperative Inc., Ithaca, NY).  A second 
aliquot without preservative was stored at -20°C until analysis for FA composition.  
On the last 2 d of the treatment period (d 27 and d 28), a third milk aliquot was 
obtained and stored at  -20°C until analysis for vitamin E content. 
 Blood samples were obtained on the last day of the treatment period (d 28) 
following the morning milking.  Blood was obtained via coccygeal venipuncture and 
collected in vacuum tubes containing sodium heparin (100 U/ml blood).  Following 
centrifugation (2,800 x g for 15 min at 4°C), plasma was harvested and stored at -20°C 
until analysis for vitamin E content. 
 
Fatty acid analysis 
 Milk samples from each week (3 samples/d, 2 d/wk) were combined for FA 
analysis to form one weekly milk composite per cow.  The extraction of milk fat was 
based on the method of Hara and Radin (1978) and the transmethylation of the 
esterified FA according to the method of Christie (1982) as modified by Chouinard 
(1999).  Briefly, hexane:isopropanol was used to extract the milk fat and sodium 
methoxide served as the methylation reagent. The resulting FA methyl esters were 
quantified by gas chromatography (Hewlett Packard GCD system HP 6890+, Hewlett-
Packard, Avondale, PA) fitted with a CP-Sil 88 fused-silica capillary column (100m x 
0.25 mm i.d. with 0.2 µm film thickness; Varian Instruments, Walnut Creek, CA).   
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Table 5.1.   Ingredient and chemical composition of the basal diet1 
 
Variable  
 Ingredient, % of DM  
    Corn silage 33.4 
    Kansas hay 10.6 
    Wheat straw 2.5 
    Hay crop silage 14.5 
    Grain mix2 38.9 
Chemical analysis, % of DM  
    CP 18.2 
    ADF 24.8 
    NDF 39.2 
    Crude fat 4.4 
NEL, Mcal/kg of DM3 0.72 
Soybean oil supplement4  
 
1Values represent average of samples forming a composite from all 4 wk of the 
treatment period and do not include the top-dressed vitamin E supplement or soybean 
oil supplement.  
2Grain mix contained 21.6% corn grain, 16.5% canola meal, 15.0% wheat midds, 
14.5% corn germ meal, 12.3% soybean hulls, 7.9% soybean meal (48% CP), 2.9% 
calcium carbonate, 2.9% rumen bypass fat (Cargill, Inc.), 2.1% blood meal, 2.1% 
sodium bicarbonate, 1.0% salt, 0.4% urea, 0.2% magnesium oxide, 0.2% calcium 
sulfate, 0.1% selenium blend (contained 0.06% sodium selenite), 0.07% trace mineral 
mix and 0.06% vitamin ADE.  The trace mineral mix contained (DM basis) 0.022% 
calcium, 18.8% selenium, 30.3 g/kg copper, 42.6 g/kg manganese, 3.37 g/kg cobalt, 
2.02 g/kg iodine, and 53.7 g/kg zinc. The vitamin ADE contained 36 IU/g vitamin A, 
7 IU/g vitamin D, and 70 IU/kg vitamin E (DM basis). 
3Net energy for lactation. 
4As a percent of total fatty acids, soybean oil consisted of 9.21% 16:0, 3.52% 18:0, 
17.66% 18:1, 60.85% 18:2 and 8.17% 18:3. 
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The initial oven temperature was set at 80°C and ramped to 190°C at 2°C/min and 
held for 15 min.  FA peaks were identified and recoveries quantified using pure 
methyl ester standards (GLC-569; NuChek Prep, Elysian, MN), and a butter oil 
reference standard (CRM 164; Commission of the European Communities, 
Community Bureau of Reference, Brussels, Belgium) was periodically analyzed as a 
control for column performance and correction factors for individual FA. 
 
Vitamin E analysis 
 Vitamin E analysis was performed using HPLC as described by Weiss and 
Wyatt (2003).   Briefly, α-tocopherol was extracted from 0.5 mL plasma by adding 1 
mL ethanol (with 1% wt/vol ascorbic acid) followed by 5 mL hexane.  Hexane was 
removed and dried under N2 and the extract redissolved in 0.4 mL absolute ethanol.  
Milk was saponified and α-tocopherol extracted by the addition of 10 mL petroleum 
ether (Indyk, 1988).  The extract was dried under N2 and redissolved in 0.5 mL 
absolute ethanol.  Aliquots of the extracts were injected onto a HPLC equipped with a 
25 cm x 4.6 mm, 5-µm reverse phase column (Supelcosil LC-18, Supelco, Bellefonte, 
PA) and a UV detector.  The solvent was 92:8 methanol:water which changed linearly 
to 100% methanol over 10 min at a flow rate of 1.8 mL/min. α-tocopherol was 
quantified by using peak areas and external standards. 
 
Statistical analysis 
 Milk production variables and FA composition from the covariate 
(pretreatment) and last week of treatment (wk 4) were used for statistical analysis of 
treatment effects.  Data were analyzed using JMP 7.0 (SAS Institute Inc., Cary, NC); 
treatment (oil, vitamin E and their interaction), covariate, and block (parity) were 
included in the model as fixed effects, and cow was included as a random variable 
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nested in treatment (oil x vitamin E).  Block was removed from the statistical model 
when declared nonsignificant P > 0.01.  The temporal pattern of milk production 
variables and FA composition from the complete study was analyzed by PROC 
MIXED procedure of SAS 9.0 for repeated measures (SAS Institute Inc., Cary, NC); 
covariate, treatment (oil, vitamin E), time, and the oil x vitamin E interaction were 
included as main effects and cow nested in treatment as a random effect.  Vitamin E 
concentrations in milk and plasma were analyzed by JMP 7.0, with main effects of oil, 
vitamin E and the oil x vitamin E interaction.  Significance was reported when P < 
0.05 and trends were indicated when significance was between 0.05 < P <0.10. 
  
RESULTS AND DISCUSSION 
 
Dietary oil supplementation has the potential to affect many performance and 
milk FA variables, and this was clearly demonstrated in the current study.  DMI was 
unaffected by dietary treatment, however milk yield increased by about 9% for cows 
fed the Oil/E diet compared to all other treatments (Table 5.2); protein and lactose 
yields increased accordingly.  Milk protein percent increased with the Oil treatment, 
but there was no difference among treatments in milk protein yield.  
Oil supplementation (Oil and Oil/E treatments) caused a gradual reduction in 
milk fat percent over the treatment period (Figure 5.1), and by the end of the 4 wk this 
represented a 17% reduction as compared to non-supplemented cows (P < 0.001; 
Table 5.2).  This is a typical observation when cows are fed high-fat diets, especially 
when the basal diet consists of corn silage, a low-fiber forage high in grain, and 
readily fermentable carbohydrates.  Hay- and hay-crop silage-based diets are more 
successful at avoiding the risk of adverse effects of oil on rumen fermentation and 
fiber digestion; however, the interaction of forage and lipid supplements are not 
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Figure 5.1.  Temporal changes in the percent and yield of milk fat from cows fed diets 
supplemented with soybean oil and vitamin E.  Treatments were control diet (C), 
control plus 10,000 IU vitamin E/d (E), control plus 2.5% soybean oil (Oil), and 
control plus 2.5% soybean oil and 10,000 IU vitamin E/d (Oil/E).  Values represent 
least squares means and standard errors. 
 
 72 
completely understood and this is an active area of research (Jenkins, 1993; Roy et al., 
2006; Chilliard et al., 2007).  We observed that including the dietary vitamin E 
supplement did not prevent the oil-induced reduction in milk fat percent.  However, 
the increase in milk yield for the Oil/E treatment resulted in a milk fat yield that was 
more similar to the non-oil supplemented treatments (C and E treatment groups, 
Figure 5.1).  In addition, the corresponding increase in protein yield for the Oil/E 
treatment may suggest that nutrient partitioning or ruminal supply of microbial protein 
was increased; however, this effect was not seen when oil alone was supplemented 
(Table 5.2). 
A major objective of this study was to enhance and sustain RA concentration 
in milk fat through the dietary addition of soybean oil, and milk FA composition was 
significantly affected (Table 5.3).  RA and VA content in milk fat more than doubled 
in cows fed the Oil and Oil/E treatments compared to non-oil supplemented treatment 
groups, and these values were sustained through wk 4 (Figure 5.2).  The RA and VA 
content of milk fat was greatest at wk 1, decreased slightly, and then maintained 
through the remainder of the treatment period.  This decline at wk 1 coincided with a 
shift in the rumen biohydrogenation pathways as evidenced by the increase in 
production of alternate trans 18:1 and CLA isomers (Figure 5.2).  Similar patterns for 
changes in the RA and VA content of milk fat are consistent with the fact that ∆9-
desaturase catalyzes the endogenous synthesis of RA from VA.  Thus, the ratio of 
RA:VA represents the equilibrium for the product:substrate ratio of ∆9-desaturase.  In 
the present study, this ratio was approximately 0.35 and not affected by oil or vitamin 
E supplementation (Figure 5.4).  This ratio is similar to that observed in previous 
studies (see review by Palmquist et al., 2005).  VA consumed in dairy products in the 
diet of humans is also converted to RA via ∆9-desaturase, thus contributing to the 
physiologically effective amount of RA (Turpeinen et al., 2002).  Parodi (2003) 
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Figure 5.2.  Temporal changes in milk fat content of trans-11 18:1 and cis-9, trans-11 
conjugated linoleic acid (CLA) in milk fat from cows fed diets supplemented with 
soybean oil and vitamin E.  Treatments were control diet (C), control plus 10,000 IU 
vitamin E/d (E), control plus 2.5% soybean oil (Oil), and control plus 2.5% soybean 
oil and 10,000 IU vitamin E/d (Oil/E).  Values represent least squares means and 
standard errors. 
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estimated that dietary intake of VA was the source for about one-half the RA present 
in humans.   
 A second focus of this study was to prevent diet-induced MFD that is often 
observed when dietary oil supplements are given.  In addition to the effects on milk fat 
percent and yield discussed earlier, the diets supplemented with soybean oil also had a 
shift in the milk FA composition that is characteristic of MFD.  Specifically, the 
proportion of de novo synthesized short- and medium-chain FA decreased (<16 
carbons) and the preformed long-chain FA increased (<16 carbons) (Table 5.3; 
Bauman and Griinari, 2003; Harvatine et al., 2009).  Furthermore, we observed the 
‘trans-10 shift’ commonly seen during diet-induced MFD and the temporal pattern of 
the increase in trans-10 18:1 content of milk fat (Figure 5.3) paralleled the decrease in 
milk fat percent (Figure 5.1).  A summary of 35 studies involving 109 treatments 
demonstrated that milk fat percent is reduced as the trans-10 18:1 content of milk fat 
increases with the nadir of about 40-50% decrease in milk fat percent occurring when 
trans-10 18:1 content reaches approximately 2.0% of total FA (Bauman et al., 2006a).  
Within this range, trans-10 18:1 is not a causative factor of MFD as demonstrated by 
abomasal infusion of the pure FA (Lock et al., 2007).  However, a recent study 
demonstrated that abomasal infusion of a mixture of trans-18:1 did cause a modest 
reduction in milk fat (19.5%) when infused at a level that resulted in an exceptionally 
high trans-18:1 in the milk fat (total trans 18:1 = 10.9% and trans-10 18:1 = 4.4% of 
total milk FA; Shingfield et al., 2009).  Nevertheless, within the physiological range of 
changes in milk FA composition observed for diet-induced MFD, trans-10 18:1 is an 
indicator of altered rumen biohydrogenation pathways and this is typically related to 
MFD.  These changes in biohydrogenation intermediates are often related to increases 
in the trans-10, cis-12 CLA content of milk fat and the ability of this CLA isomer to 
inhibit milk fat synthesis is well documented (Bauman et al., 2008).  In the current 
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Figure 5.3.  Temporal changes in milk fat content of trans-10 18:1 and trans-10, cis-
12 conjugated linoleic acid (CLA) in milk fat from cows fed diets supplemented with 
soybean oil and vitamin E.  Treatments were control diet (C), control plus 10,000 IU 
vitamin E/d (E), control plus 2.5% soybean oil (Oil), and control plus 2.5% soybean 
oil and 10,000 IU vitamin E/d (Oil/E). Values represent least squares means and 
standard errors.  Trans-10 cis-12 CLA was detected at <0.01 at wk 0 and for C and E 
treatments, but is presented in this figure at 0.01 g/100g FA for graphic purposes. 
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Figure 5.4.  Ratio of conjugated linoleic acid (CLA) to trans-11 18:1 in milk fat from 
all cows during the pretreatment and treatment periods.  Treatments were control diet 
(C), control plus 10,000 IU vitamin E/d (E), control plus 2.5% soybean oil (Oil), and 
control plus 2.5% soybean oil and 10,000 IU vitamin E/d (Oil/E). Treatments are 
coded C (*); E (◊); Oil (∆) and Oil/E (+). 
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study, trans-10, cis-12 CLA more than doubled in milk fat from cows fed the Oil and 
Oil/E treatments compared to non-oil supplemented treatments.  Based on published 
investigations where relatively pure trans-10, cis-12 CLA was abomasally infused as a 
convenient method to bypass rumen bacterial alterations, de Veth et al. (2004) 
developed an equation relating the magnitude of milk fat depression to milk fat 
content of trans-10, cis-12 CLA and this equation has been recently verified 
(Shingfield and Griinari, 2007).  Applying the equation of de Veth et al. (2004) to 
results from the present study indicated that trans-10, cis-12 CLA could not fully 
explain the extent of MFD observed in cows fed the Oil and Oil/E treatments.  A 
second CLA isomer shown to inhibit milk fat synthesis is trans-9, cis-11 18:2 
(Perfield et al., 2007), but dose-response relationships have not been established.  We 
detected trans-9, cis-11 CLA in the milk fat from cows fed the oil supplements, and 
verified its presence by GS-MS (laboratory of J. T. Brenna, Division of Nutritional 
Sciences, Cornell University; Table 5.3).  An increase in trans-9, cis-11 CLA in the 
milk fat was also observed when MFD occurred from feeding a corn silage based diet 
supplemented with a mixture of sunflower and fish oils (Shingfield et al., 2006).   
When combined with trans-10, cis-12 18:2, these two CLA isomers may be sufficient 
to account for the level of MFD observed in the current study. 
 Butyrivibrio fibrosolvens are involved in the biohydrogenation of unsaturated 
FA in the rumen; two quinol derivatives of α-tocopherol are present in cell extract of 
Butyrivibrio fibrosolvens and these act as electron donors during hydration (Hughes 
and Tove, 1980a,b; 1982).  This could provide a mechanism whereby vitamin E may 
affect rumen dynamics and aid in avoiding the ‘trans-10 shift’ and subsequent MFD.  
In the current study where MFD was induced with a dietary supplement of soybean 
oil, the addition of 10,000 IU/d of vitamin E had no effect on the percent, yield, or FA 
composition of milk fat (Tables 5.2 and 5.3).  There have been several previous 
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studies involving vitamin E supplementation at high doses but results have been 
somewhat inconsistent and difficult to compare to the present study.  Bell et al. (2006) 
reported that vitamin E supplementation (~2650-2800 IU/d) partially mitigated the 
effect of 6% safflower oil on MFD, increasing both milk fat percent and yield to 
values that approached the control; surprisingly, the FA profile was unaltered and 
remained characteristic of MFD with enhanced trans-10 18:1 and trans-10, cis-12 
CLA content in milk fat.  Charmley and Nicholson (1994) investigated effects of 
vitamin E (6000 IU/d) on oxidative stability of milk fat and observed that the addition 
of vitamin E during the last 2 wk of a 6 wk dietary treatment containing soybean and 
soybean oil supplements was able to overcome the reduction in milk fat percent; 
however, there was no statistical analysis, the actual reduction in fat percent was small 
(5%), and vitamin E specific effects on milk yield or milk fat yield were not reported.  
Focant et al. (1998) observed that adding vitamin E (9616 IU/d) to diets with 
increased PUFA from a mixture of extruded rapeseed and linseed mitigated the effect 
of the oilseeds on milk fat yield, but as in the Bell et al. (2006) investigation, the milk 
FA profile characteristic of MFD remained.  Pottier et al. (2006) investigated the 
effect of vitamin E (12,000 IU/d) on two diets formulated to induce MFD; basal diets 
were low in ADF and NDF and consisted mainly of corn silage and corn grain (~75% 
of total DM combined) as well as an additional source of fat from extruded linseeds 
and linseed oil.  They observed a 16% increase in milk fat yield and a decrease in 
trans-10 18:1 content of milk fat when the diet was supplemented with vitamin E, 
suggesting that vitamin E might prevent the ‘trans-10 shift’; however, they had no 
control group that did not receive oilseed or oil supplementation and thus it is not 
possible to assess the extent to which the oil/oilseeds induced MFD and the vitamin E 
supplement alleviated the depression.  Lastly, in a study by Kay et al. (2005) a TMR-
based diet was supplemented with vitamin E (10,000 IU/d) to compare CLA 
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concentration in milk to that of cows grazed on pasture.  While MFD was not a main 
objective, milk fat percent was lower in the TMR group as compared to pasture 
treatment and it increased when vitamin E was added to the TMR diet.  However, 
there were no corresponding significant differences in milk fat yield or milk FA 
composition.  Clearly, differences among studies involving vitamin E supplementation 
during diet-induced effects on milk fat yield and FA composition are complex, with 
variation in dietary treatments and objectives.  Nevertheless, when taken as a group, 
results from these studies indicate that supplementation with large doses of vitamin E 
may be beneficial in mitigating diet-induced MFD.  However, the present study was 
designed to examine these effects directly and our results offer no support of a role for 
vitamin E in preventing MFD induced by dietary supplements of soybean oil. 
Supplementation of 10,000 IU vitamin E/d more than doubled the vitamin E 
concentration in plasma and milk as compared to non-supplemented cows (Table 5.2).  
These values are consistent with values observed in previous studies (Atwal et al., 
1990; Charmley and Nicholson, 1994; Weiss and Wyatt, 2003; Kay et al., 2005; Bell 
et al., 2006).  Weiss and Wyatt (2003) examined the transfer of vitamin E to milk and 
demonstrated that the vitamin E transfer efficiency decreased linearly with increased 
levels of supplementation.  The transfer efficiency ranged from 1.7% to 0.78%, when 
cows were supplemented with vitamin E doses ranging from 25 to 250 IU/kd of DM, 
respectively.  In the current study with a much greater level of supplementation 
(approximately 400 IU/kg of DM), transfer efficiency of vitamin E to milk was ~0.3% 
(calculated as α-tocopherol secreted in milk (mg/d) divided by α-tocopherol intake 
(mg/d) x 100).  Increased vitamin E content in milk is of value especially for milk fats 
containing a higher proportion of unsaturated FA.  Vitamin E is best known for its 
anti-oxidative properties and has the potential to minimize the occurrence of off-
flavors in milk that lead to rancidity (Atwal et al., 1990; Focant et al., 1998).  In 
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addition, plasma vitamin E levels may benefit overall cow performance and health in 
regards to immunology and reproductive success (Weiss et al., 1997; Weiss, 1998).  
In conclusion, the present study chose a diet that is typical of Northeast dairy 
rations and supplemented the diet with oil and vitamin E in a manner that could be 
reproducible on a large-scale dairy herd by using readily available resources.  Our goal 
was to achieve a sustainable increase in the CLA content of milk fat while avoiding a 
reduction in milk fat synthesis.  The addition of soybean oil more than doubled the 
milk fat content of RA and VA and the increase was sustained over the 4 wk treatment 
period.  However, the soybean oil supplement also caused a reduction in milk fat 
percent and yield, and shifted the FA profile to that characteristic of MFD with 
increased trans-10 18:1 and CLA isomers trans-10, cis-12 and trans-9, cis-11.  The 
addition of a dietary supplement of a high dose of vitamin E did not overcome the oil-
induced reduction in milk fat percent or the changes in the FA profile, but milk yield 
was increased thereby partially mitigating the reduction in milk fat yield.  Further 
research may clarify the effects of forage source, vitamin E and plant oils on milk fat 
yield and FA composition, such that we can effectively and consistently produce milk 
fat with an enhanced RA content using dietary components typical of the Northeastern 
United States, while avoiding the economic loss of a reduced milk fat yield. 
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CHAPTER 6 
 
EFFECT OF LINOLENIC ACID, FISH OIL AND DIETARY VITAMIN E 
SUPPLEMENTATION ON SUSTAINED CONJUGATED LINOLEIC ACID 
PRODUCTION IN MILK FAT FROM DAIRY COWS 
 
INTRODUCTION 
 
Conjugated linoleic acid (CLA) is a bioactive fatty acid (FA) found almost 
exclusively in milk and meat from ruminant animals (~95%; Ritzenthaler et al., 2001) 
and its presence relates to microbial biohydrogenation of polyunsaturated fatty acids 
(PUFA) in the rumen.  The two major plant lipids, linoleic acid (18:2; LA) and α-
linolenic acid (18:3; ALA), undergo a series of isomerizations and hydrogenations in 
the rumen that typically result in stearic acid, a fully saturated FA (Harfoot and 
Hazelwood, 1997).  Cis-9, trans-11 CLA (rumenic acid; RA) and its endogenous 
precursor, trans-11 18:1 (vaccenic acid; VA) are intermediates of biohydrogenation 
and small quantities escape the rumen prior to complete saturation.  While some of the 
RA in the milk fat is of rumen origin, the majority (70-95%) is derived by endogenous 
synthesis whereby VA is converted to RA via the enzyme ∆9-desaturase (Bauman and 
Lock, 2006).  RA has been extensively investigated for its potential benefits in the 
prevention of cancer and atherosclerosis through the use of animal models, in vitro 
cell cultures, and human studies (Parodi, 2004; Bauman et al., 2006).  In addition, 
investigations have focused on methods to naturally enhance RA in cow’s milk 
through dietary modification and use of feed supplements (Lock and Bauman, 2004; 
Collomb et al., 2006; Chilliard et al., 2007). 
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Dietary supplements of oils or oilseeds that are high in PUFA are an effective 
method to enhance the RA content in milk fat.  However, PUFA are toxic to rumen 
microbes and populations may shift to accommodate the new feedstuff; as microbial 
populations change, biohydrogenation pathways are altered and unique CLA isomers 
are produced, some of which are known to induce milk fat depression (MFD) 
(Shingfield and Griinari, 2007; Harvatine et al., 2009).  Researchers have examined 
different feeding strategies to substantially enhance the RA content of milk fat while 
avoiding this ‘trans-10 shift’ leading to MFD, but this has been challenging (Lock et 
al., 2008).   
The use of dietary supplements that provide PUFA have been widely studied, 
including plant and fish oil sources (Chilliard et al., 2007; Jensen, 2002; Bauman and 
Lock, 2006).  Oils rich in LA and ALA have similar effects on RA content in milk fat 
(Chilliard et al., 2000; Glasser et al., 2008), however ALA may have an advantage in 
preventing MFD because biohydrogenation of ALA has not been shown to produce 
trans-10, cis-12 CLA (Harfoot and Hazelwood, 1997; Kelly et al., 1998a; Chilliard et 
al., 2000).  Fish oil supplements are also of interest because several investigations 
have demonstrated that low levels of fish oil (< 1.0%) appear to inhibit the final step 
of rumen biohydrogenation of VA to stearic acid (18:0), thus increasing the amount of 
VA to be used for endogenous synthesis of CLA in the mammary gland (Shingfield et 
al., 2003; Palmquist and Griinari, 2006).  When fed together, a blend of plant and 
small quantities of fish oils were most effective in raising RA content in milk fat by 
supplying 18 carbon precursors and encouraging VA accumulation (AbuGhazaleh et 
al., 2002; Whitlock et al., 2002; Whitlock et al., 2006).  Lastly, recent investigations 
have suggested a possible role for vitamin E to prevent the shift in rumen 
biohydrogenation pathways thereby mitigating the risk of subsequent milk fat 
depression (Focant et al., 1998; Bell et al., 2006; Pottier et al., 2006).  Hence, the 
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objective of the current study was to examine if low levels of fish oil in addition to 
supplementary linseed oil with or without vitamin E would improve sustainability of 
enhanced CLA content in milk fat while minimizing a diet-induced reduction in milk 
fat production. 
 
MATERIALS AND METHODS 
 
Animals and Experimental Design 
 All procedures involving dairy cows were approved by the Cornell University 
Institutional Animal Care and Use Committee.  Lactating Holstein cows (36 
multiparous, 12 primiparous) were assigned to a completely randomized block design 
for 48 d and fed one of the following treatment diets: 1) control (CON), 2) basal plus 
2.5% linseed oil (LIN), 3) basal plus 2.5% linseed oil plus 0.5% fish oil (LF), and 4) 
basal plus 2.5% linseed oil plus 0.5% fish oil plus 10,000 IU vitamin E/d (LFE).  The 
linseed oil was supplied by ADM Co. (Archer Daniels Midland, Red Wing, 
Minnesota) and the menhaden fish oil was provided by Omega Protein, Inc. (Houston, 
Texas).  The vitamin E supplement (dl-α tocopheryl acetate) was supplied by DSM 
Nutritional Products (Parsippany, New Jersey). A 2-wk pretreatment period served as 
the covariate for baseline values.  Linseed and fish oils were fully mixed into the TMR 
whereas the vitamin E supplement was top-dressed once daily. 
 Cows were housed in individual tie stalls at the Cornell University Teaching 
and Research Center (Harford, NY).  They were fed a basal TMR diet formulated 
using the Cornell Net Carbohydrate and Protein System (Fox et al., 2004) to meet or 
exceed their nutritional requirements (NRC, 2001).  Cows were fed ad libitum 
allowing 10% refusals, with fresh feed offered once daily.  Fresh feed samples were 
taken weekly and dried at 50°C for 72 h for DM determination.  Monthly feed 
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composites were formed and analyzed by wet chemistry procedures for CP, ADF, 
NDF and ether extract (Table 6.1; DairyOne Cooperative Inc., Ithaca, NY).  The ether 
extract was saved for FA analysis, and FA composition of the TMR and lipid 
supplements are reported in Table 6.2.  Fresh water was available at all times. 
 Cows were milked 3 times per day, and milk weights recorded.  Duplicate 
samples were collected from each milking on the last 2 d of each week; one set of 
samples was stored with bronopol preservative at 4°C until mid-infrared analysis for 
fat, true protein, lactose and SCC (Method 972.160, AOAC, 2000; Dairy One 
Cooperative Inc., Ithaca, NY).  The second set of milk samples was immediately 
frozen and stored at -20°C until analyzed for FA. 
 
Fatty Acid Analysis 
 Milk samples from each week were combined to form a single weekly milk 
composite for each cow.  Milk fat was extracted according to Hara and Radin (1978) 
and the transmethylation of the esterified FA was based on the method of Christie 
(1982) as modified by Chouinard et al. (1999), using sodium methoxide as the 
methylation reagent.  TMR ether extract, linseed oil, and fish oil was analyzed for FA 
composition; methylation utilized 1% methanolic sulfuric acid (Christie, 1989).  Milk 
and feed FA methyl esters were quantified by gas chromatography (Hewlett Packard 
GCD system HP 6890+, Hewlett-Packard, Avondale, PA) fitted with a CP-Sil 88 
fused-silica capillary column (100 m x 0.25 mm i.d. with 0.2 µm film thickness; 
Varian Instruments, Walnut Creek, CA).  The initial oven temperature was set at 80°C 
and increased to 190°C at 2°C/min and maintained for 20 min, then increased to 
225°C at 10°C/min and maintained for 12 min.  FA peaks were identified and 
recoveries quantified using pure methyl ester standards (GLC-569; NuChek Prep, 
Elysian, MN).  In addition, a butter oil reference standard (CRM 164; Commission of 
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Table 6.1.   Ingredient and chemical composition of the basal diet1 
 
Variable  
 Ingredient, % of DM  
    Corn silage 30.6 
    Hay crop silage 27.9 
    Corn, fine ground 15.8 
    Grain mix2 24.8 
Chemical analysis, % of DM  
    CP 15.9 
    ADF 24.6 
    NDF 34.7 
    Crude fat 4.3 
NEL, Mcal/kg of DM3 0.73 
 
1Values represent average values from all 4 wk of the treatment period and do not 
include oil or vitamin E supplements. 
2Grain mix contained 25.0% corn germ meal, 15.0% cereal tailings, 14.9% wheat 
midds, 12.5% distillers grains, 8.4% canola meal, 7.0% molasses, 4.9% blood meal, 
2.9% calcium carbonate, 2.8% sodium bicarbonate, 2.0% citrus pulp, 1.5% salt, 1.2% 
dextrose, 0.8% urea, 0.4% magnesium oxide, 0.2% magnesium sulfate, 0.2% 
selenium blend (contained 0.06% sodium selenite), 0.1% trace mineral mix and 0.1% 
vitamin ADE.  The trace mineral mix contained (DM basis) 0.022% calcium, 18.8% 
selenium, 30.3 g/kg copper, 42.6 g/kg manganese, 3.4 g/kg cobalt, 2.0 g/kg iodine, 
and 53.7 g/kg zinc.  The vitamin ADE contained (DM basis) 30 IU/g vitamin A, 6 
IU/g vitamin D, and 94 IU/kg vitamin E. 
3Net energy for lactation. 
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Table 6.2.   Composition of major fatty acids in lipid supplements and total mixed 
rations 
 
 Oil Supplements  TMR 
Fatty acid, g/100g Linseed Fish  CON1 LIN LF/LFE2 
≤ C14:0 0.04 9.56 1.20 0.20 0.93 
C16:0 5.24 16.19 19.04 12.68 12.16 
C16:1 - 13.44 0.22 0.15 1.27 
C18:0 3.33 3.10 10.78 4.14 3.67 
C18:1 19.45 5.70 24.71 23.24 21.71 
C18:2 16.38 1.35 32.85 29.65 27.21 
C18:3 53.68 1.08 4.22 23.36 24.38 
C20:5 -  14.84  -   - 0.87 
C22:5 -  2.48  -   - 0.14 
C22:6 -  12.18  -   - 0.63 
Other3 1.89 21.97 6.98 6.58 6.98 
 
1Treatments were: control diet (CON), basal + 2.5% linseed oil (LIN), basal + 2.5% 
linseed oil + 0.5% fish oil (LF), and basal + 2.5% linseed oil + 0.5% fish oil + 10,000 
IU vitamin E (LFE). Note: Control diet contained 1% Energy Booster in lieu of plant 
and fish oils. 
2TMR used for the LF and LFE treatments was identical prior to the top-dressing of 
vitamin E, thus only one value is reported. 
3Other fatty acids identified in fish oil supplements included 17:0, 20:0, 18:4 n-3, and 
20:4 n-3. 
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the European Communities, Community Bureau of Reference, Brussels, Belgium) was 
analyzed to control for column performance and correction factors for individual FA. 
 
Statistical Analysis 
 Milk production variables and FA composition from the covariate (pre-
treatment) and last week of treatment (wk 4) were used for statistical analysis for 
sustainability.  Data were analyzed using JMP 7.0 (SAS Institute Inc., Cary, NC); 
treatment, covariate, and block (parity) were included in the model as fixed effects, 
and cow nested in treatment was included as a random effect.  For all analyses, block 
was removed from the statistical model when declared nonsignificant at P > 0.1. In 
addition, temporal analysis of milk production and FA variables from the pre-
treatment and all 4 wks of study were analyzed by PROC MIXED procedure of SAS 
9.0 for repeated measures (SAS Institute Inc., Cary, NC); block, covariate, treatment, 
time and the interaction of time and treatment were included as main effects, and cow 
nested in treatment as a random effect.  Significance was reported when P < 0.05 and 
trends between 0.05 < P < 0.10. 
 
RESULTS AND DISCUSSION 
 
 Cow performance variables are reported in Table 6.3.  DMI decreased by 
13.6% for cows fed the LF and LFE treatments compared to CON and LIN (P < 
0.001).  Consistent with the reduction in DMI, numerically the LF and LFE treatments 
had a lower milk yield and in the case of the LFE treatment, the 7.6% reduction was 
significant (P < 0.02).  Milk protein percent decreased when cows were fed the LIN 
treatment (P < 0.01), and when combined with the reduction of milk yield, milk 
protein yield decreased for cows fed the LF treatment, and slightly decreased for the 
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Table 6.3.   Least squares means and standard error for performance of lactating dairy 
cows during week 4 of treatment 
 
 Treatment1    
Variable CON LIN LF LFE SEM P-value2 
DMI, kg/d  26.8a 26.1a 22.7b 23.0b 0.37  <0.001 
Milk yield, kg/d 41.5ab 42.6a 38.3ab 37.7b 1.21 0.013 
Milk fat       
     % 3.69a 3.21b 2.09c 2.24c 0.11 <0.001 
     kg/d 1.56a 1.36b 0.77c 0.84c 0.05 <0.001 
Milk protein       
     % 3.02ab 2.97b 3.10ab 3.15a 0.04 0.009 
     kg/d 1.25a 1.26a 1.16b 1.18ab 0.03 0.032 
Milk lactose       
     % 4.92ab 4.94a 4.85b 4.90ab 0.03 0.061 
     kg/d 2.04ab 2.11a 1.84b 1.84b 0.06 0.002 
 
1Treatments were: control diet (CON), basal + 2.5% linseed oil (LIN), basal + 2.5% 
linseed oil + 0.5% fish oil (LF), and basal + 2.5% linseed oil + 0.5% fish oil + 10,000 
IU vitamin E (LFE).  Note: Control diet contained 1% Energy Booster in lieu of plant 
and fish oils. 
2Probability of significant differences among treatments.  P > 0.10 is reported non-
significant (NS). 
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LFE treatment (P < 0.032).  Chilliard et al. (2009) previously reported a reduction in 
DMI and milk yield with linseed oil supplementation in cows fed a corn-silage-based 
diet.  However, dietary supplements of linseed oil resulted in an increased milk yield 
in cows fed a hay- or hay/corn silage-based diet (Loor et al, 2005a; Bu et al., 2007).  
In addition to the lower DMI as a basis for the reduction in milk yield in the present 
study and that of Chilliard et al. (2009), the oil supplement may also have affected 
rumen fermentation to an extent that fiber digestion was reduced (Martin et al., 2008; 
Beauchemin et al., 2009).   
Milk fat synthesis and FA composition can be markedly influenced by dietary 
oil supplements, and this was clearly demonstrated in the present study.  As compared 
to CON, milk fat percent was reduced 13.0% for the LIN treatment and approximately 
41% for LF and LFE treatments (P < 0.001; Table 6.3).  With the added reduction of 
milk yield, milk fat yield decreased further for cows fed the LF and LFE treatments, 
representing ~48% of the CON (P < 0.001).  Similar effects on milk fat percent and 
yield have been observed in other studies involving dietary supplements of linseed oil 
(Kelly et al., 1998a; Chilliard et al., 2009), but this has not been observed in all 
investigations (Dhiman et al., 2000; Loor et al., 2005a).  Chilliard et al. (2009) has 
suggested that these differences may relate to the level of NDF in the diet with MFD 
being observed for low-NDF diets. 
We observed that providing a dietary supplement at 10,000 IU/d had no effect 
on milk fat output as evidenced by the LFE treatment group (Table 6.3 and Figure 
6.1).  These results are similar to our previous study where a high dose of vitamin E 
(10,000 IU/d) was unable to mitigate the MFD that occurred with a diet containing 
2.5% soybean oil (Chapter 5).  However, other studies have reported that a high dose 
supplement of vitamin E was able to mitigate MFD that was induced by diets 
containing extruded rapeseed and linseed (Focant et al., 1998) or safflower oil (Bell et 
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Figure 6.1.  Temporal changes in milk fat percent and yield from cows fed different 
diets. Treatments were control diet (CON), basal + 2.5% linseed oil (LIN), basal + 
2.5% linseed oil + 0.5% fish oil (LF), and basal + 2.5% linseed oil + 0.5% fish oil + 
10,000 IU vitamin E (LFE).   
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al., 2006).  Interestingly, for both of these studies the milk fatty acid composition 
remained characteristic of diet-induced MFD even when the vitamin E supplement 
was provided.   Pottier et al. (2006) also examined effects of vitamin E on milk fat 
production; they reported that a high dose supplement of vitamin E (12,000 IU/d) 
increased the milk fat output as compared to unsupplemented diets that contained 
extruded linseeds or linseed oil. The function of vitamin E on rumen biohydrogenation 
has not been established.  It has been suggested by Kay et al. (2005) and Pottier et al. 
(2006) that vitamin E may modify rumen microbial populations because it serves as an 
electron donor during the biohydrogenation of RA to VA in Butyrivibrio fibrisolvens, 
(Hughes and Tove, 1980a,b) thus potentially increasing its viability.  Nonetheless, 
differences in basal diet, forage type and forage:concentrate ratio, and type and 
quantity of lipid supplements could potentially alter microbial populations and their 
interaction with vitamin E in the rumen and thereby impact vitamin E’s effectiveness 
to mitigate diet-induced MFD. 
 Milk FA composition was markedly effected by diet; at wk 4 of treatment, a 
FA composition characteristic of diet-induced MFD was apparent to varying degrees 
for all dietary treatments as compared to control (Table 6.4).  This assessment is 
particularly evident when FA are summed according to their origin; short chain de 
novo FA (< 16 carbons in length) are made new within the mammary gland whereas 
long chain preformed FA (>16 carbons in length) originate from blood lipids and body 
stores, and FA of 16 carbons in length originate from both sources (Bauman and 
Griinari, 2003).  While the production quantities for both de novo and preformed FA 
are reduced in milk fat during diet-induced MFD, de novo FA decrease more 
dramatically because altered rumen biohydrogenation promotes trans-10, cis-12 CLA 
production, a FA isomer that has been well documented to inhibit enzymes involved in 
de novo FA synthesis (Harvatine et al., 2009).  This results in a shift in the proportion 
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Table 6.4.  Least squares means and standard errors for fatty acid composition of milk 
fat from cows during wk 4 of treatment 
 
1Treatments were: control diet (CON), basal + 2.5% linseed oil (LIN), basal + 2.5% 
linseed oil + 0.5% fish oil (LF), and basal + 2.5% linseed oil + 0.5% fish oil + 10,000 
IU vitamin E (LFE).   
(Note: Control diet contained 1% Energy Booster in lieu of plant and fish oils.) 
2Probability of significant differences among treatments.  P > 0.10 is reported non-
significant (NS). 
3CLA = conjugated linoleic acid. 
 
 Treatment1    
Variable CON LIN LF LFE SEM P-value2 
 --- percent of total fatty acids ---   
C4:0 3.71a 3.42a 2.06b 2.03b 0.13 <0.001 
C6:0 2.23a 1.83b 0.87c 0.88c 0.06 <0.001 
C8:0 1.31a 1.01b 0.41c 0.44c 0.04 <0.001 
C10:0 2.85a 2.16b 0.87c 0.99c 0.06 <0.001 
C12:0 3.16a 2.34b 1.31c 1.48c 0.07 <0.001 
C14:0 10.39a 8.76b 6.90c 7.31c 0.15 <0.001 
C14:1 0.85b 0.74c 1.16a 1.20a 0.05 <0.001 
C15:0 0.87a 0.71c 0.78b 0.78b 0.01 <0.001 
C16:0 31.71a 23.50b 23.95b 24.71b 0.62 <0.001 
C16:1 1.57b 1.24c 2.67a 2.60a 0.14 <0.001 
C17:0 0.57a 0.42c 0.45b 0.45b <0.01 <0.001 
C18:0 11.12b 13.30a 7.55c 7.54c 0.29 <0.001 
C18:1, t-6-8 0.22c 0.49b 0.91a 0.93a 0.04 <0.001 
C18:1, t-9 0.21c 0.41b 0.73a 0.77a 0.04 <0.001 
C18:1, t-10 0.33c 0.87b 6.26a 4.22a 0.96 <0.001 
C18:1, t-11 0.91c 2.43b 6.71a 6.46a 0.45 <0.001 
C18:1, t-12 0.42c 0.91b 1.59a 1.66a 0.06 <0.001 
C18:1, c-9 21.02b 25.69a 20.13b 20.42b 0.45 <0.001 
C18:2, c-9, c-12 2.46 2.52 2.64 2.59 0.05   <0.10 
C20:0 0.09 0.10 0.09 0.09 <0.01 NS 
C18:3 0.39c 0.52b 0.56a 0.57a 0.02 <0.001 
CLA,2 c-9, t-11 0.38c 0.94b 2.70a 2.62a 0.18 <0.001 
CLA, t-9, c-11 <0.01c <0.01c 0.14a 0.11b 0.01 <0.001 
CLA, t-10, c-12 <0.01c <0.01bc 0.01ab 0.01a <0.01 <0.001 
C20:4 0.12a 0.08b 0.05c 0.05c <0.01 <0.001 
C20:5 0.04 0.04 0.03 0.02 <0.01 NS 
C22:5 0.06a 0.06ab 0.05b 0.05b <0.01 0.05 
C22:6 <0.01b <0.01b 0.02a 0.02a <0.01 <0.001 
Other 3.16c 5.00b 6.97a 7.34a 0.28 <0.001 
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of FA from each source, and in the present study, de novo FA were decreased 
substantially for treatments that included lipid supplements (25.3, 21.0, 14.2, and 
14.9% of total FA for CON, LIN, LF, and LFE treatments, respectively; P < 0.001) 
while preformed FA increased in a reciprocal manner (38.4, 49.2, 51.6, and 50.3% of 
total FA for CON, LIN, LF, and LFE treatments, respectively; P < 0.001).  Dietary 
supplements of plant oils, including linseed oil, are effective to reduce enteric 
production of rumen methane (Martin et al., 2008; Beauchemin et al., 2009).  Thus, 
the shift in milk FA composition that is characteristic of diet-induced MFD is also 
correlated with a reduction in methane production, and Chilliard et al. (2009) have 
developed equations to predict methane production based on changes in the FA 
composition of milk fat.   
Trans-10, cis-12 CLA increased slightly from undetectable levels (< 0.01%) to 
0.01% total FA (Table 6.4) for cows fed the LF and LFE treatments.  Relating this to 
the dose-response curve established for trans-10, cis-12 CLA versus milk fat percent 
(de Veth et al., 2004), this low concentration of trans-10, cis-12 CLA cannot account 
for the dramatic reduction in milk fat synthesis we observed (Table 6.3); more 
recently, two additional CLA isomers known to induce MFD have been identified, 
trans-9, cis-11 (Perfield et al., 2007) and cis-10, trans-12 (Saebo et al., 2005).  While 
we were not able to identify cis-10, trans-12 CLA, milk fat content of trans-9, cis-11 
CLA increased considerably with dietary oil supplementation, from undetectable 
levels (CON treatment) to 0.14 and 0.11% total milk FA for LF and LFE treatments, 
respectively.  Combined with trans-10, cis-12 CLA, these two CLA isomers may 
potentially explain the level of MFD observed for these treatments (Table 6.3).  
Previous studies have reported increases in the trans-9, cis-11 CLA content of milk fat 
during diet-induced MFD (Shingfield et al., 2006; Chapter 5), but this is not common.  
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The current study confirms the importance of identifying additional CLA isomers and 
their prevalence in milk fat of cows with diet-induced MFD.  
Another indication of MFD is the ‘trans-10 shift’ in rumen biohydrogenation.  
This was apparent in the current study for lipid-supplemented diets, where by wk 2 the 
concentration of trans-10 18:1 in milk fat had increased markedly and the ratio of VA 
to trans-10 18:1 had decreased (Figure 6.2).  Trans-10 18:1 was originally thought to 
directly affect milk fat synthesis in a manner similar to trans-10, cis-12 CLA; 
however, when pure trans isomers were infused into the abomasum, no MFD occurred 
when trans-10 18:1 was infused at a level similar to what would typically be produced 
during diet-induced MFD (42.6 g/d; Lock et al., 2007).  Recently, Shingfield and 
colleagues (2009) suggested that trans-18:1 FA may cause MFD at very high doses; 
they abomasally infused a mixture of trans 18:1 isomers (247 g/d; 37.3% trans-10 
18:1) and concluded that trans-10 18:1 may have been responsible for the 19% 
reduction in milk fat that was observed.  However, the direct effect of trans-10 18:1 
was not examined in this study and the dose of trans-10 18:1 in the supplement was 
more than twice the rumen outflow that occurs in diet-induced MFD (Lock et al., 
2007).  Therefore, the cause of MFD in the study by Shingfield et al. (2009) is 
uncertain and could potentially be due to the very large dose of trans-18:1 isomers or 
other isomers in the infused FA mixture. 
 Linseed oil plus fish oil supplementation successfully enhanced beneficial FA 
in milk fat.  The concentrations of RA and VA were markedly increased in milk from 
cows fed the LF and LFE treatments as compared to CON (Table 6.4), and this 
increase was sustained through wk 4 (Figure 6.2).  RA has been extensively 
investigated for its potent anticarcinogenic and antiatherogenic properties in 
biomedical studies with animal models of human disease (Bauman and Lock, 2006; 
Bauman et al., 2006b).  VA has also been shown to be anticarcinogenic (Corl et al., 
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Figure 6.3. Relationship between trans-11 18:1 and cis-9, trans-11 conjugated 
linoleic acid (CLA) from pre-treatment and all wks of treatment. Treatments were 
control diet (CON), basal + 2.5% linseed oil (LIN), basal + 2.5% linseed oil + 0.5% 
fish oil (LF), and basal + 2.5% linseed oil + 0.5% fish oil + 10,000 IU vitamin E 
(LFE).  Marker legend is as follows: CON (*), LIN (x), LF(∆), and LFE (+).  
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2003) and this activity is due to its conversion to RA via ∆9-desaturase (Lock et al., 
2004).  The relationship of RA to VA in milk fat is generally about 1:3 and in the 
present study the ratio was 0.34 (Figure 6.3).  Humans can utilize VA in the 
endogenous synthesis of RA (Turpeinen et al., 2002) and by combining dietary intake 
data with isotopic kinetic results, Parodi (2003) estimated that about one-half of RA in 
humans would be derived from endogenous synthesis from VA.  Thus, increases in the 
VA concentration of milk fat, such as observed in the current study, are of value and 
add to the physiological amount of RA.   
Few studies have achieved a similar sustainable RA content in milk fat.  Bell et 
al. (2006) fed an alfalfa/barley based diet supplemented with 6% safflower or flaxseed 
oil plus 150 IU/kg DM vitamin E for 8 wks and observed RA content in milk fat to be 
3.48 and 2.80%, respectively. Roy et al. (2006) fed a similar hay-based diet 
supplemented with linseed, and RA content in milk fat enhanced to 2.89% of the total 
FA and was sustained through the 21 d treatment period.  Both studies reported minor 
or no occurrence of MFD, unlike the present study.  The decreased milk fat yield 
could be a result of using a poor fiber source with highly fermentable carbohydrates 
(i.e. corn silage).  Rumen biohydrogenation has been shown to be less complete with 
corn silage as compared to hay and hay crop silages, increasing trans-10 18:1 and 
trans-10, cis-12 CLA in milk fat (Shingfield et al., 2005; Chilliard et al., 2007).  
However, an underlying goal of this study was to formulate a diet that would be 
available and sustainable year-round in the Northeastern United States, where corn 
silage is typically the main forage source. 
 Omega-3 FA are also of interest because of their human health effects related 
to cardiac health, neurological disorders and fetal development (Simopoulos, 1999; 
Gebauer et al., 2006; Yashodhara et al., 2009). In the current study, ALA increased by 
~50% (0.39 to 0.56% of total milk FA), whereas eicosapentaenoic acid (20:5; EPA) 
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and docosahexaenoic acid (22:6; DHA) were either unchanged or slightly increased 
from undetectable concentrations (Table 6.4).  The omega-3 FA in milk fat primarily 
consists of ALA in very low concentrations (~0.5% of total FA), and other studies 
have examined the effect of dietary supplements of plant oils or oilseeds high in ALA, 
for example linseeds or flaxseeds, as a means to improve the omega-3 FA content in 
milk fat (see reviews by Jensen (2002), Lock and Bauman (2004) and Chilliard et al. 
(2007)).  However, the chronic omega-3 FA health benefits relate to the very-long 
chain omega-3 FA, EPA and DHA, both of which are in very low quantities in milk 
fat (Jensen, 2002; Yashodhara et al., 2009).  Unfortunately, the conversion of ALA to 
EPA and DHA in humans is minimal due to the low activity of the enzyme ∆6-
desaturase (James et al., 2003; Whelan and Rust, 2006).  Thus, while an impressive 
increase in the ALA content of milk fat is often obtained, this increase is of very 
limited value because 1) the actual amount represents a minor contribution to the daily 
human requirement for omega-3 FA and 2) the ability to convert ALA to the effective 
isomers of omega-3 FA is minimal.  
Supplementation with small quantities of fish oil (<1%) can be used to enhance 
the RA content in milk fat.  Although fish oil is not a source of 18 carbon precursors 
to CLA, it appears to inhibit the final step of biohydrogenation of VA to stearic acid, 
thus increasing VA available to the mammary gland for endogenous synthesis of RA 
and secretion into milk fat (Chilliard et al., 2001; Shingfield et al., 2003).  However, 
fish oil is a risk factor for diet-induced MFD and titration studies have examined the 
effect of different levels of fish oil on the performance and milk composition variables 
(Donovan et al., 2000; Palmquist and Griinari, 2006; Whitlock et al., 2006).  Fish oil 
was most effective in raising RA content in milk fat when fed together with a plant oil 
or oilseed that provides 18 carbon PUFA precursors (AbuGhazaleh et al., 2002; 
Whitlock et al., 2002).  This result was also observed in the current study, where the 
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LF and LFE treatments markedly increased RA and VA concentration in milk fat as 
compared to the LIN treatment (~280% increase; Table 6.4).  However, the fish oil 
dramatically reduced milk fat synthesis by 41% compared to the LIN treatment.  
These diets were not isocaloric, and this effect may be due to the total fat content in 
the diet (3.0% vs. 2.5%) and/or the addition of fish oil, but neither can be confirmed 
without further investigation. 
Overall, studies examining the potential to enhance CLA in milk fat vary in 
forage source, quantity and source of plant and fish oils.  While this study did not 
observe benefits of vitamin E on milk fat or FA composition, it may be of value in 
milk by preventing oxidation of the enriched PUFA content in experimental milk, and 
also potentially improve immune function and health of the dairy cow (Focant et al., 
1998; Weiss, 1998).  Enhancement of RA in milk provides the opportunity for dairy 
products to benefit human health and well-being through naturally occurring 
functional food components, and is of increasing interest to the public and health 
professionals.  In the current study, RA content in milk fat was increased to a level 
that could be physiologically effective (Bauman et al., 2006b), however the challenge 
remains to establish a viable method to mitigate diet-induced MFD that occurs with 
increased PUFA supplementation.   
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CHAPTER 7 
 
ENHANCING OMEGA-3 FATTY ACIDS IN MILK FAT OF DAIRY COWS 
BY USING STEARIDONIC ACID-ENRICHED SOYBEAN OIL FROM 
GENETICALLY-MODIFIED SOYBEANS 
  
INTRODUCTION 
 
 Very long chain (VLC) omega-3 (n-3) polyunsaturated fatty acids (PUFA) are 
essential for growth and development, and beneficial in the maintenance of human 
health and the prevention of chronic diseases including cardiovascular disease, 
inflammatory diseases and neurological disorders (Gebauer et al., 2006; Wang et al., 
2006; Yashodhara et al., 2009).  Dietary sources of eicosapentaenoic acid (EPA; 
20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) are mainly marine algae, fish and 
fish oils. Nevertheless, the estimated intakes of VLC n-3 PUFA are very low despite 
the dietary guidelines, and the vast majority of the population consumes substantially 
less than the recommended levels (Ursin, 2003; Gebauer et al., 2006).  Hence, there is 
a need to develop alternative food sources to increase consumption of VLC n-3 PUFA 
(Whelan and Rust, 2006). 
Milk fat levels of omega-3 fatty acids are typically very low, less than 0.5% of 
total fatty acids, and this is mainly α-linolenic acid (ALA; 18:3n-3) (Jensen, 2002).  
ALA is an essential omega-3 fatty acid for some development processes; however, 
conversion of ALA to VLC n-3 PUFA is necessary for other physiological functions 
and essential for optimum health and the prevention of chronic diseases (Wang et al., 
2006; Lavie et al., 2009; Yashodhara et al., 2009).  This conversion requires ∆6-
desaturase (Figure 7.1), an enzyme that is limiting in humans (James et al., 2003; 
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Figure 7.1.   Biosynthesis of omega-3 fatty acids 
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Whelan and Rust, 2006).  Stearidonic acid (SDA; 18:4n-3), a product of the ∆6-
desaturation of ALA which overcomes the rate-limiting step in omega-3 metabolism 
(Figure 7.1), is of interest as a possible precursor of VLC n-3 PUFA (Ursin, 2003; 
Whelan, 2009).  Genetic modification of oilseeds such as soybeans (SBO) is an 
approach that can be used to increase the SDA in soybean oil (SBO) (Ursin, 2003) and 
toxicology studies have confirmed the safety of SDA-enhanced SBO (Hammond et al., 
2008).  Our objectives were to examine the potential of using SDA-enhanced SBO to 
increase the omega-3 fatty acid content of milk fat in dairy cows and to determine the 
efficiency of SDA uptake from the digestive tract and its transfer to milk fat. 
 
MATERIALS AND METHODS 
 
Animals and design 
All procedures involving animals were approved by the Cornell University 
Institutional Animal Care and Use Committee.  Three multiparous, pregnant, rumen-
fistulated Holstein cows averaging 267 DIM were assigned randomly to a 3 x 3 Latin 
square design.  Prior to the start of the first period, cows were fitted with abomasal 
infusion lines (0.5cm i.d. polyvinyl chloride tubing) passing through the rumen fistula 
and sulcus omasi (Lock et al., 2007).   Treatments were as follows: 1) control (no oil 
infusion); 2) abomasal infusion of SDA-enhanced SBO (SDA-abo) and 3) ruminal 
infusion of SDA-enhanced SBO (SDA-rum).  Oil was stored in aliquots at 4°C and 
warmed to room temperature prior to infusion.  Oil infusions (210 g/d) provided 57 
g/d of stearidonic acid and infusion periods were 7 d with a 7 d washout between 
periods.  Equal amounts of oil were infused into either the rumen or abomasum at 6 h 
intervals as previously described (Castañeda-Gutiérrez et al., 2007).  At each infusion, 
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cows receiving the oil treatments were given the bolus of oil followed with 120 ml of 
water to flush the line; control cows received only the water flush.   
Cows were housed in individual tie stalls at Cornell’s Large Animal Research 
and Teaching Unit and fed ad libitum a dry diet that was formulated to meet 
requirements (NRC, 2001) using the Cornell Net Carbohydrate and Protein System 
(Fox et al., 2004).  Fresh feed was offered twice daily at 700 and 1900 h, and orts were 
determined daily.  The forage was a mixture of alfalfa hay and grass hay, and the 
TMR was 50:50 forage:concentrate.  Feed samples were taken weekly and composites 
were formed and analyzed by wet chemistry procedures for DM, 90%; CP, 17.6%; 
NDF, 40.6%; ADF, 25.0%; and ether extract, 3.1% (Dairy One Cooperative, Inc., 
Ithaca, NY).  Cows were exercised daily and fresh water was available at all times.  
Cows were milked twice daily at 700 and 1900 h with two milk samples obtained at 
each milking, and daily milk weights were recorded.  One aliquot was stored with 
bronopol preservative at 4°C until mid-infrared analysis for fat, true protein, lactose 
and SCC (Method 972.160, AOAC, 2000; Dairy One Cooperative Inc., Ithaca, NY).  
A second aliquot without preservative was immediately stored at -20°C until analyzed 
for fatty acids. 
 
Fatty acid analysis 
Fatty acids were extracted and methylated as previously described (Tyburczy 
et al., 2008).  Milk FA methyl esters were quantified by gas chromatography (Hewlett 
Packard GCD system HP 6890+, Hewlett-Packard, Avondale, PA) fitted with a CP-Sil 
88 fused-silica capillary column (100 m x 0.25 mm i.d. with 0.2 µm film thickness; 
Varian Instruments, Walnut Creek, CA).  The initial oven temperature was set at 80°C 
and increased to 190°C at 2°C/min and maintained for 20 min, then increased to 
225°C at 10°C/min and maintained for 12 min.  FA peaks were identified and 
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recoveries quantified using pure methyl ester standards (GLC-569; NuChek Prep, 
Elysian, MN).  In addition, a butter oil reference standard (CRM 164; Commission of 
the European Communities, Community Bureau of Reference, Brussels, Belgium) was 
analyzed periodically to monitor column performance and correction factors for 
individual fatty acids.  Identification of less common omega-3 milk fatty acids was 
confirmed using GC-Mass Spectrometry by the laboratory of J. T. Brenna (Division of 
Nutritional Sciences, Cornell University). 
Transfer efficiency was calculated on an individual cow basis and accounted 
for the incremental increase in secretion of the infused  fatty acids in milk fat.  The 
difference between baseline secretions and the average of d 6 and d7 secretions of 
fatty acids in milk fat was determined, and this was expressed as a proportion of the 
amount of fatty acid isomer infused daily. 
 
Statistical analysis 
Data were analyzed as a 3x3 Latin square design using the PROC GLM 
procedure of SAS (Version 5, SAS Institute, Cary, NC).  The model to test treatment 
means included the random effect of cow and fixed effects of treatment and period.  
Effects were declared significant at P < 0.05.  One cow suffered a physical injury and 
had to be removed from the study just prior to the start of her third period (abomasal 
infusion) resulting in a missing cell.   
 
RESULTS AND DISCUSSION 
 
The SDA-enhanced soybean oil contained 27.1% SDA, 10.4% ALA and 7.3% 
γ- linolenic acid; relative to the typical fatty acid composition of SBO, these fatty acid 
increases were offset mainly by a reduction in linoleic and oleic acids (Table 7.1).  
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Infusion of the SDA-enhanced SBO into the rumen or abomasum had no effect on 
DMI or milk production; across treatments daily DMI and milk production averaged 
(least-squares mean ± SE) 22.9 ± 0.5 kg and 32.3 ± 0.9 kg, respectively.  Likewise, 
treatments did not differ in milk protein percent and yield (3.24 ± 0.04% and 1.03 ± 
0.02 kg/d, respectively) or milk lactose percent and yield (4.88 ± 0.05% and 1.55 ± 
0.05 kg/d, respectively).  In the case of milk fat, yield was unaffected by treatment 
(1.36 ± 0.03 kg/d), but milk fat percent was less (P<0.01) for the SDA-rumen 
treatment (4.04 ± 0.04%) as compared to control (4.30 ± 0.04%) and abomasal 
treatment (4.41 ± 0.05%).  PUFA are biohydrogenated in the rumen and this often 
results in the production of fatty acid intermediates that inhibit mammary synthesis of 
milk fat (Harvatine et al., 2009).  These effects are less pronounced or negligible when 
the intake of PUFA is reduced or meal frequency is increased (Bauman and Griinari, 
2001).  In the present study the rumen infusion treatment supplied only ~52 g SBO 
every 6 h; thus, the minimal effects on milk fat percent were as expected.  
Examination of milk fatty acid composition revealed that many fatty acids 
were unchanged, but changes were observed in some fatty acids and these were as 
expected based on specific treatments.  None of the individual saturated fatty acids 
differed among treatments (data not presented), and across treatments the saturated 
fatty acids represented 61.0 ± 2.1% (least-squares mean ± SE) of total milk fatty acids.  
Among the monounsaturated fatty acids, oleic acid was unaffected by treatment.  
However, consistent with rumen biohydrogenation of the infused PUFA there were 
significant increases in the milk fat content of trans-18:1 isomers for the rumen 
infusion group (Table 7.2); generally these increases were of small magnitude with the 
largest occurring for vaccenic acid (trans-11 18:1) which approached 2% of total milk 
fatty acids.  Vaccenic acid originates as an intermediate in rumen biohydrogenation of 
18-carbon PUFA and it is converted to cis-9, trans-11 18:2 (conjugated linoleic acid; 
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CLA) by the mammary enzyme ∆9-desaturase (Bauman et al., 2006a); consistent with 
this, the CLA content of milk fat was also increased for the SDA-rum treatment (Table 
7.2).   
As expected, the SDA-abo treatment resulted in increases in the fatty acid 
content of several PUFA in milk fat (Table 7.2).  Of special interest were increases in 
the fatty acids in the omega-3 biosynthesis pathway (Figure 7.1), specifically ALA, 
SDA, eicosatetraenoic acid (ETA), and EPA.  Milk fat content of docosapentaenoic 
acid (DPA) and DHA, two additional VLC n-3 PUFA (Figure 7.1), did not differ
 
Table 7.1.   Major fatty acids in the stearidonic acid-enriched soybean oil  
 
Fatty acid SDA-enhanced SBO1 Soybeans2 
 ---------- Percent of total fatty acids ---------- 
Palmitic acid, 16:0 12.50 11.4 ± 1.9 
Stearic acid, 18:0 4.26 4.1 ± 0.6 
Oleic acid, 18:1 14.66 22.3 ± 2.5 
Linoleic acid, 18:2n-6 18.42 53.5 ± 3.2 
γ-Linolenic acid, 18:3n-6 7.25 
7.0 ± 1.93 
α-Linolenic acid, 18:3n-3 10.43 
Stearidonic acid, 18:4n-3 27.10 - 
 
1Stearidonic acid-enhanced soybean oil 
2Values are mean ± SD of 44 soybean oil seed supplements as reported by Glasser et 
al. (2008) 
3Reported as linolenic acid 
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Table 7.2.   Partial listing of milk fatty acids and the effect of treatment 
 
Fatty Acids Treatment1  
 Control SDA-abo SDA-rum P1 
 ----- Percent of total milk fatty acids ----- 
Oleic acid, 18:1, c9 25.09 ± 1.49 22.10 ± 1.97 26.03 ± 1.49 NS 
Trans fatty acids     
18:1, t6-8 0.27b ± 0.01 0.20b ± 0.02 0.35a ± 0.01 0.02 
18:1, t9 0.22b ± 0.01 0.18b ± 0.01 0.32a ± 0.01 0.01 
18:1, t10 0.37b ± 0.01 0.34b ± 0.02 0.48a ± 0.01 0.02 
18:1, t11 1.07b ± 0.11 0.96b ± 0.15 1.96a ± 0.11 0.02 
18:1, t12 0.38b ± 0.03 0.25b ± 0.04 0.60a ± 0.03 0.01 
Linoleic acid, 18:2n-6 3.30b ± 0.20 5.81a ± 0.26 2.96b ± 0.20 0.01 
γ- Linolenic acid, 18:3n-6 0.04b ± 0.01 0.57a ± 0.01 0.05b ± 0.01 0.0001 
α-Linolenic acid, 18:3n-3 0.44b ± 0.02 1.55a ± 0.03 0.43b ± 0.02 <0.01 
RA, 18:2, c9, t11 0.45b ± 0.03 0.31b ± 0.05 0.70a ± 0.03 0.01 
SDA, 18:4n-3 <0.01b 1.86a ± 0.02 0.07b ± 0.02 0.0001 
ARA, 20:4n-6 0.17 ± 0.01 0.19 ± 0.01 0.15 ± 0.01 NS 
ETA, 20:4n-3 0.04b ± <0.01 0.23a ± <0.01  0.04b ± <0.01 0.0001 
EPA, 20:5n-3 0.06b ± 0.01 0.18a ± 0.01 0.05b ± 0.01 0.01 
DPA, 22:5n-3 0.08 ± <0.01 0.08 ± <0.01 0.07 ± <0.01 NS 
DHA, 22:6n-3 <0.01 <0.01 <0.01 NS 
 
1Probability of significant difference among treatments. Within a row differences are 
indicated by different superscripts.  NS = nonsignificant at P > 0.1. 
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among treatment groups (Table 7.2).   For the SDA-abo treatment, the temporal 
patterns of ALA, SDA, ETA and EPA illustrated a progressive increase following the 
initiation of infusion reaching a plateau by d 3 and 4 of infusion (Figure 7.2).   
Overall, the omega-3 content of milk fat was 3.9% of total milk fatty acids with the 
SDA-abo treatment, a value more than 500% greater than milk fat from the control 
group (Table 7.2).  When abomasal infusion was terminated, milk fat content of these 
fatty acids progressively decreased to pre-infusion values following a mirror-image 
pattern of the increase.  In contrast, rumen infusion had little or no effect on omega-3 
fatty acids, and milk fatty acid values were similar to the control treatment (water 
infusion) (Figure 7.2 and Table 7.2).   
The transfer efficiency of SDA to milk fat represented 39.3% (range = 36.8 to 
41.9%) of the SDA present in the abomasally infused oil.  If increases in the omega-3 
fatty acids downstream from SDA are included (ETA + EPA; Figure 7.1), then the 
transfer efficiency for SDA increases to 47.3% (range = 45.0 to 49.6%).  If there was 
substantial conversion of ALA to SDA and to downstream omega-3 fatty acids it 
would reduce the calculated transfer efficiency of SDA.  However, this contribution 
would appear to be minor; Hagemeister et al. (1991) reported that abomasal infusion 
of linseed oil to dairy cows markedly increased the milk fat content of ALA, but the 
increase in the EPA content of milk fat was minimal representing only 1.3% of that 
observed for ALA.   Just as observed for humans and other species (James et al., 2003; 
Whelan and Rust, 2006), ∆6-desaturase appears to be rate limiting in the conversion of 
omega-3 fatty acids in lactating dairy cows.  In the current study the transfer efficiency 
of abomasally-infused SDA plus downstream intermediates synthesized from SDA 
(ETA and EPA) is similar to reports of transfer efficiency for linolenic acid, and 
greater than the transfer efficiency typically reported for EPA and DHA.  While 
variation was substantial, a literature summary of infusion studies by Chilliard et al.
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(2000) indicated most transfer efficiency values tended to be ~40 to 60% for linolenic 
acid and a similar summary of EPA and DHA infusions to lactating cows indicated 
milk fat transfer efficiencies were generally about 20 to 30% (Lock and Bauman, 
2004).  In contrast to abomasal infusion, we observed the transfer efficiency of 
ruminally-infused SDA to milk fat averaged only 1.7% (range = 1.3 to 2.1%).  Thus, 
rumen biohydrogenation of SDA must be extensive and substantially increasing the 
omega-3 content of milk fat will require that dietary supplements of SDA-enriched 
SBO be formulated to protect the SDA from rumen biohydrogenation. 
Some food products are promoted as being “naturally” enriched in omega-3 
fatty acids.  In the case of dairy products this is generally achieved by feeding rations 
that have a higher content of α-linolenic acid (e.g. pasture, flaxseed, linseed oil) (Lock 
and Bauman, 2004; Palmquist, 2009).  The omega-3 fatty acids of special importance 
for optimal human health and the prevention of acute and chronic diseases are EPA 
and DHA; thus, the ability to metabolize ALA to VLC n-3 PUFA is an important 
nutritional consideration in humans  (Whelan and Rust, 2006; Brenna et al., 2009).  
Unfortunately, human clinical studies have demonstrated that ALA conversion to EPA 
was very limited in children and adults (Arterburn et al., 2006; Brenna et al., 2009).  
Likewise, supplements of flaxseed to increase dietary intake of ALA result in marked 
increases in the ALA content of milk fat in lactating women, but changes in EPA were 
minimal even after 4 wk of supplementation (Francois et al., 2003).  As discussed 
earlier, Hagemeister et al. (1991) observed the same limited conversion of ALA to 
EPA in lactating cows.  
 SDA is the ∆6-desaturase product of ALA, but unfortunately this enzyme has 
only limited activity in humans and as discussed earlier it represents a rate-limiting 
step in the biochemical pathway for the conversion of dietary ALA to EPA (Figure 
7.1).  SDA has been targeted as a potential intermediate for use in foods because it 
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bypasses this enzymatic step and human clinical comparisons with EPA supplements 
indicate that supplements of SDA provide EPA equivalence at moderate intakes 
(Ursin, 2003; Whelan, 2009).  There are natural sources of SDA including plants from 
the Boraginaceae family (e.g. seed oils from echium and borage), and some fish oils 
contain up to 4% SDA; however, SDA sources are limited and inadequate for wide-
scale enrichment of feeds and foods (Ursin, 2003; Whelan, 2009).  Introduction of the 
genes for ∆6- and ∆15-desaturases into soybeans allows for the conversion of linoleic 
acid to ALA (via ∆15-desaturase) and ALA to SDA (via ∆6-desaturase) resulting in the 
production of SDA-enhanced soybean oil.  Previous investigations with SDA-
enhanced SBO have evaluated the effectiveness and safety in humans (Harris et al, 
2008) and rodents (Hammond et al., 2008).  Likewise, studies with humans have also 
observed that SDA supplements resulted in elevated EPA compared to ALA 
supplements, but DHA was unaltered (James et al., 2003; Harris et al., 2008).  We also 
observed that abomasal infusion of SDA-enhanced SBO resulted in increased milk fat 
content of SDA as well as downstream intermediates ETA and EPA, but DHA was 
unaffected in lactating cows (Table 7.2). 
Dietary intake of EPA plus DHA averages ~100 mg/d for the US population 
(Ervin et al., 2004) and this compares with the recommendation of 500 mg/d for 
healthy individuals and 800 to 1000 mg/d for individuals with coronary heart disease 
(Lavie et al., 2009).  Our goal was to investigate whether SDA uptake from the 
digestive tract would result in an increase in the omega-3 fatty acid content of milk fat.  
The potential impact of the observed changes in milk fatty acid composition on the US 
diet would need to be evaluated as part of a comprehensive dietary assessment.  
However, assuming industry-wide adoption and effective rumen protection 
technology, data for US dietary intakes can be combined with results from the present 
study to provide an estimate.  Using the US dietary intake of fat from dairy products 
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estimated from the National Health and Nutrition Examination Survey (Ervin et al., 
2004) and assuming that humans convert approximately 25% of dietary SDA to EPA 
(Whelan, 2006), dairy products produced from the milk of cows receiving the SDA-
abo treatment would add approximately 90 mg/d of VLC n-3 PUFA to the diet of an 
average US individual without altering fat consumption.  This would represent a 
significant contribution towards meeting the recommendation for VLC n-3 PUFA 
intake. 
 
CONCLUSIONS 
 
The present study presents the first results on the uptake and transfer of SDA 
to milk fat in dairy cows.  The SDA source was genetically-modified soybeans and our 
results demonstrated that abomasal infusion of SDA-enhanced SBO resulted in a 5-
fold increase in the omega-3 fatty acid content of milk fat, specifically increasing 
ALA, SDA, ETA and EPA.  Relative to meeting the human dietary requirements for 
omega-3 fatty acids, an increase in SDA has an advantage over ALA because humans 
can more efficiently convert SDA to EPA.  However, our results also indicate that 
rumen-protected formulations of SDA-enriched SBO would be needed to achieve 
increases in the omega-3 fatty acid content of milk fat.  Additional studies and animal 
numbers are required to more fully evaluate individual cow variation and develop 
dose-response relationships.  Nevertheless, results from the present study clearly 
demonstrate the impressive potential to utilize SDA-enhanced soybeans to achieve 
increases in the omega-3 fatty acid content of dairy products of benefit to human 
health.  
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CHAPTER 8 
 
INTEGRATED SUMMARY  
 
 The composition of milk fatty acids (FA) is of interest for human dietary 
considerations, as consumers and health professionals are increasingly aware that 
specific FA can affect human health and prevent chronic and acute diseases.  
Conjugated linoleic acid (CLA) and omega-3 FA have been shown to have potential 
anticarcinogenic and antiatherogenic properties, whereas the consumption of high 
saturated or trans FA has been negatively implicated with poor cardiovascular health. 
Milk FA composition is highly affected by diet, especially by variations in forage 
source and inclusion of lipid supplements.  Therefore, the objective of this dissertation 
was to evaluate current FA composition of retail milk in the United States and 
investigate the potential to naturally enhance and sustain bioactive FA in milk by 
using various dietary supplements.   
The last national milk retail survey was conducted in 1984, and since then 
changes in the management and feeding of cows may have impacted FA composition. 
Two separate surveys examining the FA composition of U.S. retail milk were 
conducted; the first consisted of conventionally produced milk collected from 
processing plants across the contiguous 48 states for the duration of one year, in order 
to capture regional and seasonal variations (Chapter 3).  Milk FA composition was 
found to be surprisingly consistent across all regions and seasons, although there were 
statistical differences of minor magnitude.  Thus, the increased use of TMR, lipid 
supplements and by-product feeding must be well established in all regions and in 
routine use across all seasons.  These results contrast with the seasonal effects reported 
in similar, yet less extensive, international studies.  These investigations observed 
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substantial changes in CLA and trans-18:1 FA were observed when cows were 
switched from summer pasture grazing to winter barn feeding, where changes in FA 
directly related to the availability of fresh, lush pasture.  When comparing our US 
study to 1984, the content of saturated, mono- and polyunsaturated FA were similar; 
however, due to improvements in analytical techniques, comparisons could not be 
made between CLA, trans-18:1 and omega-3 FA.  This updated report of the FA 
composition of U.S. retail milk may serve as a reference for estimating dietary intake 
of FA from dairy products, and provide baseline values for future studies, especially 
those involving enhancement of bioactive FA. 
The second survey focused on evaluating differences in FA composition of 
milk with specialty labels based on production practices (Chapter 4).  We compared 
the FA composition of conventional milk containing no specialty labeling with retail 
milk samples labeled as ‘rbST-free’ or ‘organic’.  Milk labeled rbST-free was not 
statistically different from conventional milk, but there were statistical differences 
between milk labeled organic and the conventional and rbST-free retail samples.  
Some of these differences could be considered desirable (CLA, omega-3) and some 
less desirable (saturated and trans FA), but without exception differences among 
conventional milk and milk labeled as rbST-free or organic were minor having little or 
no public health relevance.  In dairy production, diet is the main determinant of milk 
FA composition, and, in practice, organic farms as well as conventional farms can 
vary widely in feeding and diet formulations.  A wide range in the milk fat content of 
CLA and omega-3 FA was observed in organic labeled milk, where the highest and 
lowest values among all samples were observed.  This was most likely due to 
differences in feeding management and inclusion of pasture grazing, as organic 
producers are required to provide cows access to pasture in order to meet USDA 
standards for organic production.  As with the previous survey, similar international 
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studies reported differences for organic and conventionally produced milk, however 
these differences were transient over time as the availability of fresh pasture 
diminished in the winter seasons.  In addition, most of these studies obtained milk 
samples from individual farms, creating a level of variability among farms rather than 
solely comparing production practices.  Sampling of milk pooled at the processing 
plant would dilute milk from farms implementing unique feeding or management 
practices, as was the basis for our sampling technique for the US survey.  Determining 
differences between the nutritional quality of foods based on production practice is a 
growing area of research.  Results have been somewhat inconsistent and may vary due 
to sample size, nutrient examined, or reports of statistical significance for minor 
differences that are of too small a magnitude to have public health relevance.  This 
survey was the first to analyze FA composition for US retail milk that was unlabeled 
(conventional milk) and milk labeled as rbST-free or organic.  When results are 
combined with analyses of other milk variables, results indicated that all retail milk is 
wholesome and nutritious regardless of production management practice. 
Methods to naturally enhance and sustain milk bioactive FA were investigated.  
Specifically, the effect of dietary lipid supplements and vitamin E on CLA and/or 
omega-3 FA content in milk fat were examined (Chapters 5 and 6).  There is some 
evidence that high quantities of vitamin E may mitigate the milk fat depression 
typically observed with diets containing lipid supplements, however these studies have 
limitations and inconsistencies (Table 8.1), thus this effect was explored more 
thoroughly.  In Chapter 5, the addition of soybean oil more than doubled the milk fat 
content of CLA and trans-11 18:1, and the increase was sustained over the 4 wk 
treatment period.  However, the soybean oil supplement also caused a reduction in the 
percent and yield of milk fat and shifted the FA profile to that characteristic of milk fat 
depression with increased trans-10 18:1 and CLA isomers known to inhibit milk fat
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In Chapter 6, diets were supplemented with linseed oil, fish oil, and a high 
dose of vitamin E (10,000 IU/d).  Several studies have shown that a blend of plant oil 
and small quantities of fish oil were most effective in raising CLA content in milk fat.  
This was also observed in our study where CLA was markedly increased for diets 
containing both linseed and fish oils.  However, as in Chapter 5, vitamin E 
supplementation was unable to mitigate the reduction of milk fat yield when oils were 
supplemented.  Inconsistencies between studies examining the effect of vitamin E may 
be related to differences in basal diet, forage source and forage:concentrate ratio, and 
source and quantity of lipid supplements.  These variables could potentially alter 
microbial populations and their interaction with vitamin E in the rumen and thereby 
impact vitamin E’s effectiveness to mitigate diet-induced milk fat depression.  Further 
research may clarify the effects of forage source, vitamin E and plant oils on milk fat 
yield and FA composition, such that we can effectively and consistently produce milk 
fat with an enhanced CLA content while avoiding the economic loss of a reduced milk 
fat yield. 
The final investigation involved the use of genetically modified soybean oil 
enriched with stearidonic acid (SDA; 18:3 omega-3) as a novel feed ingredient to 
enhance very long chain omega-3 FA in milk fat (Chapter 7).  Eicosapentaenoic acid 
(EPA; 20:5 omega-3) and docosahexaenoic acid (DHA; 22:6 omega-3) are beneficial 
FA in preventing chronic diseases including cardiovascular disease, inflammatory 
diseases and neurological disorders.  However, the estimated US intake of EPA and 
DHA is very low despite the dietary guidelines, and the vast majority of the 
population consumes substantially less than the recommended levels.  Hence, there is 
a need to develop alternative food sources to increase consumption of EPA and DHA.  
The major dietary omega-3 FA is α-linolenic acid (18:3 omega-3; ALA).  However, 
ALA is poorly converted to EPA and DHA due to the limited activity of ∆6-
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desaturase, the enzyme responsible for converting ALA to SDA.  Therefore, the use of 
an oil rich in SDA has the potential to bypass this step and provide a valuable 
precursor for endogenous synthesis of EPA and DHA.  Chapter 7 presented the first 
investigation on the uptake and transfer of SDA to milk fat in dairy cows through 
abomasal infusion of SDA-enhanced soybean oil.  Marked increases of ALA, SDA 
and EPA in milk fat were observed and clearly demonstrated the potential use of this 
oil supplement to increase the omega-3 FA content of dairy products to benefit human 
health.  
The importance of evaluating the nutrient composition of foods is increasingly 
recognized as the interaction between diet and health is further established.  This 
dissertation evaluated two separate surveys of retail milk in the United States, and 
results may serve as a reference for recommending and determining FA intake from 
dairy products, as well as provide baseline values of ‘typical’ FA values to be 
compared with individual feeding trials altering milk FA composition.  Data from the 
above chapters illustrate the plasticity of milk fat and the opportunity to use common 
or novel lipid supplements to naturally enhance milk bioactive FA.  While the 
interaction of dietary ingredients on milk fat synthesis continues to be examined, it is 
possible to enhance CLA and omega-3 FA in milk fat to a degree that may be 
physiologically effective, thus offering the potential for additional health benefits 
through the consumption of dairy products. 
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